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Abstract 
 
 The transcription factor p63 is crucial for the maintenance and development of the epidermis. The 
p63 protein is encoded by the TP63 gene, which contains two distinct promoters giving rise to two major 
protein isoforms, termed TAp63, and ∆Np63. Mutations in the TP63 gene can lead to severe epidermal 
disease such as ectrodactyly/ecto-dermal dysplasia and cleft lip/palate (EEC) and 
ankyloblepharon/ectodermal defects and cleft lip/palate (AEC) syndromes. Within the literature there is 
conflict as to spatial and temporal expression of the p63 isoforms in developing and differentiating 
epidermis, with TAp63 appearing to play roles in the early stages of ectodermal development with ∆Np63 
thought to be the dominant isoform during the maturation and maintenance of the epidermis. Despite 
this, recent work has suggested a role for TAp63 in regulating the steps within terminal differentiation of 
keratinocytes.  
 To examine this possible role for TAp63 isoforms in terminal differentiation we induced 
differentiation in 2D cell culture of primary and immortalized keratinocyte lines. Isoform expression, 
alongside other differentiation markers, were quantified via qRT-PCR. Furthermore, siRNA knockdown 
systems were developed to knockdown total p63, all TAp63 isoforms and all Beta forms of p63 and qRT-
PCR was used to assess knockdown efficiency and effects on isoforms expression and expression of 
other linked genes.  
 Results from calcium–induced differentiation of keratinocyte lines from basal cells demonstrated 
a mirroring expression pattern for both the p63 isoforms with ∆Np63 expression being higher during the 
early stages of differentiation with its expression decreasing beyond day 8. In comparison, TAp63 
expression began to increase at day 8 of differentiation, with its peak expression after day 12 and 13 
suggesting a role for this isoform during the terminal stages of differentiation. This was seen in one 
HaCaT cell line and two primary keratinocyte lines. Expression of other differentiation markers such as 
FLG, KLF4 and ETS-1 followed expected trends.   
 Knockdown of total p63, TAp63 isoforms and Beta isoforms provided varying results in two 
keratinocyte lines. When total p63 was targeted in basal cells, we saw 50-75% knockdown of p63 
isoforms suggesting that ∆Np63 was the most prominent isoform at this stage. When TAp63 was 
targeted, we saw a 60% knockdown efficiency. When Beta isoforms were targeted, we saw between 60 
and 80% knockdown efficiency for ∆Np63 and a 30% knockdown efficiency for TAp63. We also 
demonstrated that expression of ETS-1 was consistent through two keratinocyte lines when each of the 
siRNA knockdowns were introduced.  
 We have demonstrated in vitro that the expression of the p63 isoforms shows a clear temporal 
difference in differentiating keratinocytes. We have further shown that when p63 isoform expression is 
interfered with, downstream marker expression changes depending on the target. These findings are 
important for understanding the distinguished roles of each isoform in differentiating keratinocytes.  
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Terminology  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Term Definition  
P63 Transcription factor encoded by the TP63 gene 
siRNA Short interfering RNA  
KLF4 Kruppel-like factor 4 
qRT-PCR Real time Polymerase chain reaction 
FLG Filaggrin 
ETS-1 ETS Proto-oncogene 1 
IKK-a Also known as CHUK. Conserved Helix-Loop-Helix Ubiquitous Kinase 
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1.0 Introduction 
1.1 General Introduction 
The skin is the largest organ in the human body, covering the entire outer surface of the body. It 
has a key feature in that it is a self-renewing organ. This barrier acts to prevent the entry of pathogens 
and debris whilst keeping the skin from dehydrating. In order to achieve this, different cell types work in 
unison, each with specific functions. In order to allow the cells to have a specific function, the cells must 
take on certain morphological features. These morphological features are determined by the gene 
expression within the cells. The expression of these genes are dependent on extracellular signals which 
trigger an internal cascade of expression of various transcription factors which regulate certain genes 
within the cell.  
Within the skin, there are multiple layers, each containing various cell types and cells in different 
stages of differentiation. Each layer of the skin is crucial for its own reasons allowing the maintenance, 
development and function of the skin barrier.  
1.2 The Skin and Epidermis 
 The skin is compartmentalized into three main layers - the epidermis, the dermis and the 
hypodermis. The dermis sits on the internal layer, the hypodermis, comprising of the connective tissue, 
blood vessels, nerve endings, sweat glands and hair follicles. The hypodermis itself is a subcutaneous 
layer of fat, which functions as insulation for the body, whilst also providing protective qualities. The 
epidermis is the outermost component of the skin, being the “true” skin. The cooperation between both 
the dermis and the epidermis achieves the functionality of the skin as a barrier, protecting the body from 
external insults whilst maintaining a balance of water movement. Both layers interact forming a highly 
specialized matrix structure 
called the basement 
membrane. The basement 
membrane acts to separate 
the two layers whilst providing 
stability as well as a dynamic 
interface (Breitkreutz et al., 
2009).Despite the organ as a 
whole being responsible for 
the active skin structure, the 
epidermis is the most 
important compartment for 
preventing water and other 
compound loss as well as a 
protective element from the 
environment.  
 The epidermis is a self-
renewing epithelial structure 
that is subdivided further into 
Figure 1: Human epidermal structure: The innermost layer comprising of 
cells with self-renewing qualities associates with the basement membrane. 
The spinous layer and granular layer provide the other nucleated layers 
with the enucleated stratum corneum on the outermost edge of the 
epidermis (Baroni et al., 2012) 
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multiple strata. The innermost layer of the epidermis, forming connections with the basement membrane, 
is the basal layer. Moving upwards through the epidermis, the spinous layer sits on top of the basal 
membrane. The outermost layer of live cells is called the granular layer containing tight junctions that 
seal neighboring cells in this layer. Within the layers of the nucleated cells, desmosomes interconnect 
adjacent cells. The outermost structures are predominantly made up of lipids and dead keratinized cells 
called the stratum corneum. The stratum corneum’s role is to protect the rest of the skin components 
providing adaptive immunological, chemical and biochemical barriers (Wickett & Visscher, 2006) (Figure 
1). 
 The cells of the basal layer are responsible for the self-renewing quality of epidermis with 
approximately 15% of the cells at the basal layer being part of this process, with the other cells being in 
a quiescent state (Baroni et al., 2012). Within the epidermis the most commonly found cell type is 
keratinocytes and these cells are nucleated and present from the basal layer right through to the granular 
layer (Proksch et al., 2008). Keratinocytes synthesize structural proteins and lipids which are key for the 
epidermal structures and function. Keratinocytes are also responsible for the stratum corneum, with this 
structure being made up of enucleated keratinocyte cells which have been differentiated throughout a 
migration through the epidermal layers. These cells act through keratin filaments and are surrounded by 
a cell envelope which is composed of cornified envelope proteins.  
  
1.3 Skin Development in Embryogenesis and Epidermal Commitment  
 The current literature exploring the process of human skin development at a foetal age is limited. 
Despite this, the development of human skin has been studied at a morphological level using electron 
microscopy approaches (Peltonen et al., 2010). The development of skin in the fetal stages of 
development are crucial for the survival of the individual due to fetal skin having advantageous properties 
such as scar less wound repair (Walmsley et al., 2015).  
 During embryonic and fetal development, many orchestrated gene regulation pathways must take 
place allowing for proper organogenesis. These processes must occur in the correct spatial and temporal 
situations for the desired organ and systems to develop. In order for the steps to take place in the right 
order, these processes must be tightly controlled by specific transcription factors including p63. Historic 
studies of p63 have showed the importance of p63 in embryonic epidermal development as well as in 
keratinocyte proliferation and differentiation (Carroll et al., 2006; Pellegrini et al., 2001; Truong et al., 
2006).   
 As shown in mouse models, p63 has an essential role in proper epidermal commitment (Mills et 
al., 1999). During the early stages of vertebrate development, the surface epithelium is a single layer of 
Keratin 8 and Keratin 18 positive cells (Aberdam, 2008) .This layer has a function of allowing cellular 
diffusion, secretion and absorption. As the development process continues, this group of ectodermal cells 
develop into the keratinocyte cells, which express high levels of Keratin 5 and 14. These keratins are 
expression markers associated with mature epithelial cells (Soares & Zhou, 2018). This change in 
physiological states is known as epidermal commitment and this process is tightly controlled by p63. As 
a result, p63 is known as the “gatekeeper” of epidermal commitment (Shalom-Feuerstein et al., 2011) 
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 Spatio-temporal analyses using mouse embryos have demonstrated that p63 is present at the 
limb buds and branchial arches initially, and then expands into the whole surface of the embryo (Zhao et 
al., 2015). This expression pattern correlates with the affected structures such as epidermis and limbs. 
Work using knock out mouse models have further confirmed the importance of p63.  
 Despite the importance of p63 in epidermal commitment being widely respected, the molecular 
pathways and cascades remain to be fully uncovered. This means work into this area is needed further 
to note the action of p63 and which isoforms are responsible.  
1.4 Keratinocyte Lifecycle  
  The architecture of the stratum corneum gives rise to the permeable barrier function of the 
mammalian epidermis. The stratum corneum is made up of highly organized cellular compartments with 
lipid compartments interspaced (Houben et al., 2007). In order to maintain this barrier, there is need for 
constant replenishment of cells. This renewal of cells is created by a balance of loss of the outermost 
cells and generation of new cells at the basal level. The generation of new keratinocytes is exclusive to 
the most internal layer of the epidermis, the stratum basale. At this level, there are high levels of 
proliferation, forcing a large amount of cells to migrate towards the most external point. In doing so, these 
cells undergo differentiation, eventually arriving at the point when they are terminally differentiated into 
corneocytes.   
 This process takes approximately one month in human skin, but can mimicked in vitro over a 
shorter period of time. In order to reach terminal differentiation, the cells must undergo a number of 
morphological changes that are determined by a series of events. During the migration, the keratinocytes 
undergo cornification and generate extracellular lipid domains between cells. These events begin during 
the movement through the stratum spinosum and continues more proficiently in the stratum granulosum.  
 Finally, to reach terminal differentiation, the cells undergo epidermal programmed cell death in 
which the cells detach through loss of cell-cell adhesion (Ishikawa et al., 2015). This loss of the most 
terminal cells, allows the process of renewal to carry on. This process is different from the classical 
apoptotic pathways, in which there is programmed cell death either intrinsically or extrinsically.  
1.4.1 Keratinocytes at the Basal Layer 
 In the basal layer of the epidermis a subpopulation exists which are responsible for maintaining 
the process of replacing terminally differentiated cells with new keratinocytes. This population have other 
roles including the repair or replenishment of damaged cells. The cells in this population maintain a slow 
cell cycle and hence a long life span with a high proliferative potential. Found predominantly in the bulge 
of hair follicles, these cells can migrate, taking up space in the basal layer between hair follicles (Jahoda 
& Reynolds, 2000). The epidermal stem cells found in this population replicate asymmetrically (Figure 
2), meaning one single stem cell divides and gives rise to two daughter cells which may be two new cells, 
one stem cell and one transit amplifying cell or two transit amplifying cells (Watt, 2001). The product of 
the division is determined by the need of the epidermis at that time.  
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 If a transit-
amplifying cell is 
produced as a 
daughter cell, this 
allows the 
proliferation of the 
cells to continue. 
Each transit-
amplifying cell is 
able to divide a set 
number of times 
before the progeny 
of this population 
moves towards 
terminal 
differentiation. In 
order to do this, they 
must remove 
themselves from the 
cell cycle. This 
process results in 
multiple 
differentiating cells from one individual stem cell. This allows maintenance of the stem cell populations at 
the basal layer, without affecting the number of differentiating cells produced (Watt et al., 2000).  
 The fate of stem cells is determined by the need of the epidermis and is controlled by expression 
of various markers. The signals can determine the fate of epidermal stem cells. As a result, we can use 
the markers to understand the cascade of events throughout the differentiation process. Also, these 
signals can be hijacked or artificially-induced in various therapies and used in the laboratory (Chunmeng 
& Tianmin, 2004). An example of a marker expressed by epidermal stem cells is β1-integrin. The 
expression of β1-integrin is believed to be involved with adhesion to the basement membrane. Adhesion 
to the basement membrane inhibits differentiation of keratinocytes as it prevents the migration through 
the layers of the epidermis. Additionally, other markers are expressed at this basal level. These markers 
are thought to be more specific to keratinocytes, many of which are isolated to the cells in this basal state.  
  A key marker for keratinocyte differentiation is p63. This is a transcription factor that is 
expressed in basal keratinocytes and throughout differentiation. This marker is the main marker that is to 
be investigated in this thesis and will be discussed at greater length in Sections 1.5 and 1.6.  
1.4.2 Process of Cornification  
 Identification of cells, which have been released from the basal layer, is apparent due to the 
morphological changes to the structure. The cells, which have been released into the upper layers of the 
epidermis, express a number of different genes which induce these phenotypic changes. These cells 
also lose their replicative ability at this stage. Genes which were previously expressed at the basal layer, 
such as Keratins 5, 14 and 15 are down regulated, whilst upregulation of differentiation-specific keratins 
Figure 2: Schematic representation of the asymmetrical nature of stem cell 
division in the stratum basale. One stem cell division allows multiple daughter cells 
that are then allowed to proceed to terminal differentiation. Modified from (Watt, 
2001).  
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such as Keratin 1 and 10 is induced (Yano 
et al., 2005). These keratins that are 
specifically expressed in the suprabasal 
layers can form the heteropolymers which 
eventually make up part of the cytoskeletal 
elements, along with actin filaments and 
microtubules. In unison, these subunits 
allow migration of organelles and structural 
roles for the cells.  
 Once suprabasal keratinocytes 
differentiate further into the granular layer, 
new morphological structures appear. 
These structures are known as 
keratohyalin granules (Figure 3). These 
granules are primarily made up of a protein 
called profilaggrin (Houben et al., 2007). 
Through proteolysis and 
dephosphorylation, profilaggrin is 
processed into the mature form of the 
protein- filaggrin (Brown & McLean, 2012). Filaggrin’s function is to aid the aggregation of the keratin 
filaments at the boundary between the straum granulosum and the stratum corneum, through a process 
known as the “ionic zipper hypothesis” (Mack et al., 1993). Filaggrin also has been shown to have other 
roles, including roles within the distribution of cytoskeletal elements including actin microfilaments 
(Presland et al., 2001). Furthermore, the NH2 terminal filaggrin has been demonstrated to have nuclear 
activity in gene transcription of genes associated with the subsequent differentiation steps (Pearton et 
al., 2002) whereby it acts within the nucleus itself. The protein passes through the nuclear membrane 
and acts directly in gene transcription.  
 Another structural protein, which is isolated to the keratohyalin granules, is loricrin. This protein 
becomes cross-linked to the cornified envelope. The events of the formation of the cornified envelope is 
triggered initially by rising Ca2+ concentration in the differentiating keratinocytes (Kalinin et al., 2002).  
This begins in the upper levels of the stratum spinosum. The increasing calcium ion concentration 
encourages the proteins called periplakin and envoplakin to form heterotetramers to which involucrin 
Figure 3: Cartoon representation of the epidermis with the 
stratum granulosum labelled. The flattened polygonal cells at 
this layer contain keratohyalin granules made of filaggrin 
filaments. 
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becomes bound via the 
action of the enzyme 
transglutaminase 1 
(Kalinin et al., 2004). A 
protein scaffold, which is 
reinforced by a lipid 
envelope, makes up the 
extracellular matrix. A 
summary of the events 
leading to the formation 
of the cornified layer is 
depicted in Figure 4.  
1.4.3 Cell death and 
Desquamation 
 The terminal 
differentiation of 
keratinocytes results in 
the cells dying. Given 
that the internal state of 
the cells is now mainly 
intermediate filaments 
and structural elements, 
the membrane-bound 
organelles can be 
destroyed and the DNA 
within the cell is degraded 
(Candi et al., 2005).  
During normal 
keratinocyte cornification, 
a process which is distinct 
from normal apoptosis is 
undertaken. This sequence is programmed, similar to the programmed nature of both apoptotic 
pathways, but this process begins as soon as the keratinocyte leaves the basal layer of the epidermis. 
This phenomenon is termed “epidermal programmed cell death”. The ways in which this differs from 
classical apoptosis is that the corneocytes are not destroyed via phagocytosis, the cytoskeleton of the 
cell is not degraded, but instead reorganized and the nucleus is destroyed via a different pathway during 
epidermal programmed cell death. Moreover, many of the caspases which are usually activated during 
apoptosis are not activated (Lippens et al., 2005). Instead, caspase 14, which is exclusively expressed 
in epidermal cells, becomes active during terminal differentiation, but not during classical apoptosis 
(Tschachler, 2005). Despite these cells in the cornified layer being dead, they still play a crucial role in 
the epidermal barrier function until they finally detach from the outermost layer of the skin through a 
process called desquamation.  
Figure 4: Schematic representation of the stages leading to the formation of 
the cornified layer of the epidermis. Key proteins that are expressed at these 
steps are shown on the right. Keratins 5, 14 and 15 are replaced by K1 and 
K10 allowing the intermediate filaments to form. The keratohyalin granules 
release Filaggrin, allowing it to aid the aggregation of other microfilaments. 
Loricrin is expressed to reinforce the cornified envelope resulting in complete 
cornification. (Houben et al., 2007) 
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 The process of desquamation involves the degradation of desmosome, the complexes that 
adhere keratin filaments to one another. Desmosomes, much like the cells, undergo changes as they 
move through the epidermis too. In the cornified layers, the corneodesmosomes interact with multiple 
proteins. It is the enzymatic proteolysis of the interactions between these proteins which allow 
desquamation (Ishida-Yamamoto et al., 2018). The degradation of the linkages between the 
desmosomes and structural proteins has been extensively studied using ultrastructural microscopy 
(Chapman & Walsh, 1990).  
 In order for these sequences of events to correctly take place during differentiation, the genes 
involved need to be tightly controlled by transcription factors. One of the most important in epidermal 
differentiation is the transcription factor p63.  
1.5 p63 Structure and Function 
 The 
transcription factor, 
p63 is known as a 
master regulator and is 
responsible for the 
control of expression 
of multiple genes. 
Many of the genes that 
are regulated by p63 
are associated with 
development. As a 
transcription factor, its 
role is to bind to the 
upstream region of 
target genes and 
recruit proteins 
associated with the 
transcription initiation 
complex (Little & 
Jochemsen, 2002). The gene encoding for the p63 protein (TP63) is mapped to the chromosomal location 
of 3q27-29 (Kaelin Jr, 1999). As a member of the p53 family of transcription factors, p63 shares certain 
homology to the other p53 family members- p53 and p73 (Melino et al., 2003). One highly conserved 
domain within each of the three family members is the DNA-binding domain (Figures 5 and 6). This 
domain is crucial for the interaction between the transcription factor and the DNA itself so any mutation 
in this region would be detrimental to the function of the protein (Natan & Joerger, 2012).  
The gene contains two distinct promoters (Figure 6), each giving rise to different isoforms. Any 
mRNA transcribed using the most 5’ promoter encode p63 isoforms that contain the transactivation 
domain. These are termed TA isoforms. Transcription of mRNA at the most 3’ promoter results in 
products lacking the transactivation domain. These isoforms are termed ∆N forms (Figure 6). In addition 
to the distinct promoters, alternative splicing leads to further complexity within each class of isoform. 
Within the TA and ∆N classes, the alternative splicing creates three different C-termini, termed α, β and 
Figure 5: Schematic representation of the homology between the p53 family 
members. A) Features of each of the family members (TA: Transactivation 
domain, DBD: DNA-binding domain, OD: oligimerisation domain, SAM: sterile 
alpha motif. B) Percentage homology of each of the key regions of the p53 family 
members (Melino et al., 2003). 
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γ (Orzol et al., 2012). Further additional splicing of both the TA and ∆N isoforms at their C- terminal ends 
generate at least 10 different p63 isoforms. These species are termed α, β, γ, δ and ε (Mangiulli et al., 
2009). The ∆N forms lack the TA domain and have a negative inhibitory effect on the transcriptional 
activation by the TA isoforms (Moll & Slade, 2004). ∆Np63 isoforms contain an ability to activate a smaller 
subset of genes due to the presence of a TA2 domain found at the C- terminal end. In addition, the sterile 
alpha domain (SAM) is present in the α form of ∆Np63 and this is thought to be involved with protein-
protein interactions (Ghioni et al., 2002). Furthermore, a transcriptional inhibitory domain (TI) can inhibit 
the transcriptional activity of the TA and ∆Np63α isoforms (Kim & Bowie, 2003) (Figure 6).  
p63 is one of the most commonly found markers in keratinocytes and is widely reported as being 
responsible for maintaining the proliferative potential of basal stem cells whilst also moderating and 
controlling the differentiation process in the epidermis.  
 
 
  
 
 
 
 
 
 
 
 
Figure 6: Varying transcripts of TP63 gene derived from two distinct 
promoters and alternative splicing. TAp63 subclass occur due to promoter 
I exon 1 allowing transcription of transactivation domain. ∆Np63 subclass 
has absence of transactivation domain due to promoter being in 3’ exon. 
Each transcript (α, β and γ) caused by alternative splicing at 3’ end (Orzol 
et al., 2012). 
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1.6 Key Roles of p63 as a Transcription Factor 
 Historically, mouse models have been used for gene expression studies, however knockout 
models for p63 resulted in early death of the offspring, with lack of development of epidermal appendages 
(See 1.7). This observation suggests that p63 had clear implications in epidermal development (Mills et 
al., 1999; Yang et al., 1999). Moving away from mouse models and using high throughput gene 
expression analyses and 
cell culture approaches 
have allowed a greater 
depth of understanding 
of the expression and 
regulatory roles of p63. 
As a transcription 
factor, p63 acts on a high 
number of target genes 
either resulting in 
upregulation or 
downregulation of the 
target. As a result, p63 
plays an important role in 
a variety of cellular 
regulation processes: 
many involved with 
development. These 
pathways include: 
development of 
cytoskeletal elements, 
cytoskeletal remodeling, internal cell signaling, DNA repair and activating certain microRNAs (Botchkarev 
& Flores, 2014). In addition, p63 can act as a transcriptional repressor to genes that inhibit the cell cycle 
and transcriptional signaling (Su et al., 2013).  
 As seen in Figure 7, p63 can interact with multiple targets within each of the pathways (Botchkarev 
& Flores, 2014). p63 itself is part of its own regulatory control as activation of certain microRNAs such as 
MiR-203 (Lena et al., 2008; Yi et al., 2008), MiR-720 and MiR-574-3p (Chikh et al., 2011) can in turn 
affect the expression of p63 in a self-regulating loop. Additionally, the TP63 gene is regulated by other 
transcription factors: DEC1 and Setd8. Setd8 is a protein –lysine N-methyltransferase which acts through 
monomethylation of either histones or non-histone proteins while DEC1 is less known, but has been 
implicated with p53 family interactions (Qian et al., 2008).  
 Some of the key pathways for development and maintenance of the epidermal barrier are p63- 
regulated. Many of the keratins associated with being the key fibrous structural proteins responsible for 
providing the mechanical stability and protection of the epidermal barrier are regulated by p63. Terminal 
differentiation markers such as loricrin and filaggrin have been described as p63- regulated which 
suggests a role for p63 not only in the maintenance and early differentiation steps but also at the terminal 
stages. In order for all steps of development and maintenance to be carried out without problems, tight 
Figure 7: The transcriptional targets of p63 found in epidermal keratinocytes 
where p63 acts a transcriptional activator and repressor. In keratinocytes, p63 
regulates specific groups of genes many of which are associated with 
development and maintenance. miRNAs, the transcription factor DEC1 and the 
methyltransferase Setd8 regulate p63 expression (Botchkarev & Flores, 2014).  
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signaling and transcriptional control must be in place, and again p63 plays a role here. Key signaling 
molecules in the epidermis such as Gata-3 (a zinc-finger nuclear transcription factor (Mertens et al., 
2015)), IKK-α (an enzyme complex that forms part of the NF-kappaB signaling cascade) and IRF6 (a 
transcription factor associated with developmental pathways) are regulated by p63 in the epidermis.  
 Given the variety of pathways that p63 is controlling, it is clear that p63 is a crucial factor for 
maintaining the correct cascade of events in a multitude of disciplines. As p63 exists as two different 
isoforms, it begs the question as to the role of the individual isoforms in orchestrating this vast network 
of processes.   
  
1.7 Isoforms of p63 
 In the literature, there is a large amount of conflict between details of the temporal expression and 
importance of each of the isoforms at different stages of development. However, there is strong evidence 
to suggest that the TAp63 isoforms play key roles in the establishment of the germline and the ectodermal 
stages. ∆Np63 isoforms are predominantly found during the proliferative stages of development and are 
Figure 8: Selected p63 isoform targets with known impact on development in epidermal tissue, 
particularly the skin. Adapted from Candi et al., 2007 
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accountable for approximately 99% of the 
p63 expression found in differentiated 
keratinocytes. However, recent studies 
have found that TAp63 isoforms are over 
expressed in terminally differentiating 
keratinocytes (Candi et al., 2007) 
 The shorter, truncated version of 
p63, termed ΔNp63, is the most commonly 
discussed isoform in literature to date in 
terms of its role in epidermal development. 
This is due to the high level of expression of 
these isoforms making studies much easier 
to carry out. Most studies carried out in mice 
contend that ∆Np63 isoforms are highly 
expressed in the early stages of epidermal 
morphogenesis and continues to be 
expressed throughout the basal layer in 
addition to other epithelial tissues 
(Laurikkala et al., 2006; Romano et al., 
2012). Research into the specific roles of 
∆Np63 has found some of the key 
mechanisms with which these isoforms are 
associated. Protein analysis has 
demonstrated that ∆Np63 forms are down 
regulated in more differentiated layers of the 
epidermis.  
 In contrast to ∆Np63, TAp63 is noted 
to be weakly expressed in the skin. 
However, it has been shown to be 
expressed prior to ∆Np63. In 
overexpression studies of TAp63, it has 
been shown that when TAp63 was 
overexpressed the cells went into a 
hyperproliferative state meaning TAp63 was 
able to prevent the cells going into 
differentiation. This function was noted only 
for the TAp63 isoforms. The authors of this 
work speculate that TAp63 is the molecular 
switch, which is responsible for the 
pluristratification of the epidermis, and that 
∆Np63 is the counteracting force, allowing 
cellular differentiation. (Koster et al., 2004) 
These findings are in contrast to other data, 
Figure 9: A) Front and sagittal views of mouse control 
(+/+) and p63 null (-/-) E17 mice embryos. B) P63 null 
mouse pups one-day postnatal day 1. p63 -/- lacking 
eyelids, footpads, lack whisker pads and have 
hypoplastic upper and lower jaw. C) Bone and cartilage 
staining D) Hematoxylin and eosin staining of sagittal 
sections revealing malformation of maxilla (mx), 
mandible (md), and secondary palate (pa) and complete 
lack of vibrissae (vb), tooth primordia (tp) and soft tissue 
structures in null mice. E) Bone and cartilage structures 
of fore and hind limbs of E15 p63 -/- mice compared to 
control littermates. Adapted from Yang et al., 1999.  
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which suggests that ∆Np63 is the only isoform expressed in epidermal development and that it is solely 
expressed in the basal layer, where cells are undifferentiated. It is rapidly degraded throughout 
differentiation (Pellegrini et al., 2001; Yang et al., 1998).  The basis behind the contrasting theories is still 
not understood. 
 
 As a regulation dogma, the p63 system works through competition between the two isoforms 
(Candi et al., 2007). ∆Np63 has been linked to many regulatory roles, including many which repress 
transcription of cell cycle related genes such as cyclin B2, Cdc2 and topoisomerase IIα (Testoni & 
Mantovani, 2006). Additionally, cross-talk between p63 and Notch signaling can allow the modulation of 
Notch-1 dependent transcription in the process of epidermal stratification and differentiation (Rangarajan 
et al., 2001).  
 
1.8 Mutations in p63 and its Association to Disease 
 Due to its importance in multiple transcriptional regulation cascades, mutations in the TP63 gene 
can lead to severe developmental conditions. Genetic ablation of p63 in mouse models have been shown 
to result in failure of the stratification of the epidermal tissue alongside other developmental abnormalities 
such as lack of epidermal appendage formation, limb malformation or complete lack of limb formation 
(Mills et al., 1999) (Figure 9). Given the severity of the phenotype when complete p63 knockout is carried 
out; it demonstrates a clear importance for p63 in correct development of limbs and epithelial tissues. 
Additionally, heterozygous mutation in the p63 gene is generally believed to play a dominant-negative 
effect on the wild type due to formations of wild type and mutant tetramers, hence reducing the amount 
of cellular functional p63 protein.  
  
1.8.1 EEC and AEC 
In humans, mutations in the TP63 gene has severe effects also leading to many developmental 
conditions (Brunner et al., 2002). One p63-related disorder is ankyloblepheron-ectodermal dysplasia 
clefting (AEC, also known as Hay-Wells Syndrome) (Grange, 2013). This condition is a rare autosomal 
condition with fewer than 100 affected individuals mentioned in literature with the exact incidence or 
prevalence of the disorder unknown. The symptoms of this conditions present in different ways, even 
amongst family members. Many of the signs of AEC present at birth with many infants presenting with 
symptoms such as fused eyelids- ankyloblepheron filiforme adnatum. Another key sign is the erosion of 
the skin, which may be life threatening. If skin erosions occur on the scalp, this can lead to severe hair 
loss and formation of scar tissue. Throughout the patient’s life, the skin erosions may recur even into 
adulthood. These erosions are an obvious sign and can be painful. Alongside the erosions, there may be 
other signs such as redness, waxiness or dry scaly patches with hyperkeratosis of the knees and elbows. 
 Furthermore, other areas other than the skin are affected, with many epidermal tissues forming 
incorrectly. This can include signs of hypodontia, chronic inflammation of the eyelids and other limb 
formation issues.   
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The disease is genetic and many studies have investigated the cause of it. Multiple sequence 
alignments have identified that mutation in the sterile alpha motif region of the p63 protein lead to the 
disease (McGrath et al., 2001). Single nucleotide polymorphisms in this region created missense 
mutations leading to the condition, as seen in Figure 10. Despite this work, a majority of AEC- related 
mutations occur in the C terminal of p63 (Rinne et al., 2006). More recently work carried out by Russo 
(2018) on 227 AEC patients has found that protein aggregation of p63 is an underlying factor for the skin 
fragility in AEC syndrome (Russo et al., 2018). This work identified many AEC-associated p63 mutations 
that lead to thermodynamically destabilized, misfolded and aggregated protein products. These disrupted 
protein structures were shown by the work to show a higher propensity to aggregate creating a dominant-
negative effect on the wild type and that reversal of the aggregation restored normal p63 activation.  
  Another similar condition to AEC is EEC (ectrodactyly, ectodermal dysplasia and cleft lip palate). 
It again is autosomal dominantly inherited and affects the hair, nails, sweat glands and tooth formation 
(Rodini & Richieri-Costa, 1990).  p63 mutations account for the vast majority, if not all of the cases of 
classical EEC. Heterozygous mutations in the TP63 gene occur in the DNA- binding domain which is 
common in all p63 isoforms. The Arginine residues at five common positions are the most common 
abnormalities, accounting for approximately 75% of EEC cases (Brunner et al., 2002).  
Figure 10: A) results from multiple sequence alignment of p63 SAM domain alongside p73 and Sterile alpha motif 
domains which have previously been solved. Highlighted in orange are the sites for missense mutation to occur, all 
of which are present in sufferers of AEC. B) Ribbon model shows amino acids that are mutated in AEC and their 
relative positions. Space fill model shows the clustering of three mutated amino acids on protein surface (glycine 
534, threonine 537 and glutamine 540) (McGrath et al., 2001) 
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1.8.2 Psoriasis 
 Psoriasis is another skin condition of which p63 has been implicated. Psoriasis presents as 
chronic keratinization characterized by hyperkeratosis with inflammation and epidermal hyperplasia. The 
presence of hyperplasia in psoriatic epidermis are due to increased amounts of dividing keratinocytes 
(Weinstein et al., 1985). Despite this, the mechanisms underlying the epidermal remodeling associated 
with psoriasis are not fully understood. Studies have been carried out to investigate the role of p63 in 
psoriasis due to p63’s importance in proliferating keratinocytes. Studies have used stainings to identify 
spatial expression of p63 isoforms in hyper-proliferative conditions (Shen et al., 2005) along with mRNA 
and protein analyses (Gu et al., 2006).  
 High throughput transcriptomic analyses such as RNASeq in the study of diseases such as 
psoriasis allows comparison of large sample sizes to develop an understanding of disease mechanisms. 
Previously, microarray analysis of psoriatic samples revealed large numbers of differentially-expressed 
genes (Gudjonsson et al., 2010). RNASeq studies have taken the findings of microarray analysis further 
to identify unmapped transcripts and alternative splicing (Wang et al., 2009).  
 In psoriatic skin, p63 has been shown to be upregulated in particular in elongated rete edges. 
More specifically, ∆Np63α is overexpressed and this upregulation leads to further upregulation of protein 
kinase genes leading to proliferation (Shen et al., 2005). In contrast, cyclins and other cell cycle- related 
genes have been found not to be ∆Np63α regulated suggesting that p63 is not the only signal essential 
for causing the hyper-proliferative state in psoriasis (Meyerson et al., 1992; Okuda et al., 1994; Wu et al., 
2003).  
Figure 11: Expression of p63 in psoriatic skin. A) In early stages, p63 is expressed in the basal cells. B) During 
the thickening of the rete edges, strong expression of p63 is seen. C) Once rete edges have fully formed, p63 
expression is seen localized in the protruding edges. D) In fully developed psoriasis, p63 is seen in the basal cell 
layer and the lower regions of the rete edges. Adapted from Shen et al., 2005. 
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1.9 Genes of Interest 
We wanted to look at the isoforms of p63 alongside a collection of other marker genes:  
 KLF4: Kruppel-like factor 4 (KLF4) is a 
transcription factor from the Kruppel family. The 
protein is a zinc finger protein which has been 
implicated in the normal development and 
function of the skin’s barrier. KLF4 expression 
is usually found in well-differentiated, non-
proliferating cells (Ghaleb et al., 2005). In 
literature, KLF4 and p63 have been linked by 
work using ChiP (chromatin 
immunoprecipitation reactions) (Testoni et al., 
2006; Viganò et al., 2006). KLF4 will be used in 
this study due to the fact that work has 
uncovered that KLF4 is a transcriptional target 
of p63 (Cordani et al., 2010). Despite work 
identifying p63 as a transcriptional regulator of 
KLF4, it is not known as to which isoform is 
responsible.   
 FLG: Filaggrin is a structural protein 
encoded by the FLG gene and is associated 
with maintaining the barrier function of the 
epidermis. This makes it a strong marker for 
epidermal differentiation as its expression is 
expected during only the final stages of 
differentiation- making it a good marker for 
terminal differentiation. Filaggrin specifically 
interacts with keratins and other intermediate 
filaments. In addition to being a differentiation 
marker, FLG expression has been reported as 
being blocked by TA-containing isoforms of p63, more notably TAp63α and TAp63γ (King et al., 2006). 
Furthermore, the α-tail of the ΔNp63α forms block profilaggrin expression, supporting the concept of p63 
isoforms working in tandem during epidermal differentiation (Candi et al., 2007).  
 ETS-1: This protein is a member of the ETS family of transcription factors that are defined by their 
common DNA-binding domain that recognizes the consensus DNA sequence of GGAA/T. As a 
transcription factor, it acts to promote and repress gene expression. The genes associated are noted to 
be involved in stem cell development, cell senescence and death. It is normally expressed in the 
proliferative layer of the stratified epithelium (Nagarajan et al., 2010). ETS-1 is an oncogene heavily linked 
to squamous cell carcinomas: tumors with aberrations in the normal epidermal differentiation pattern 
(Bhawan, 2007). It has also been noted in literature as being a transcriptional target for TAp63 isoforms 
in epidermal differentiation pathways and is a known regulator of CHUK, another gene marker studied in 
this work (Candi et al., 2007).  
Figure 12: KLF4 expression increases during 
keratinocyte differentiation. Western Blot analysis of 
keratinocytes over a period of 10 days of 
differentiation. Immunofluorescence analysis of p63 
and KLF4 expression. Adapted from (Cordani et al., 
2010) 
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 CHUK (IKK-α): CHUK 
is a serine kinase, which plays 
an essential role in the NF-
Kappa-B pathways and can be 
activated by DNA damage, 
inflammatory cytokines or other 
cellular stresses. As a serine 
kinase, it phosphorylates 
inhibitors of the NF-Kappa-B 
pathway. These modifications 
allow the subsequent 
degradation of the proteasome 
allowing NF-Kappa-B to 
activate genes associated with 
aversion from apoptosis, 
growth control and some 
immune response applications. 
One transcription factor that 
has been demonstrated to 
regulate CHUK expression is 
ETS-1 during epidermal 
differentiation (Candi et al., 
2007) (Figure 13).  
 TGM1: This gene encodes the transglutaminase 1 enzyme. This enzyme is found in the epidermis 
and is involved with the cornified envelope formation. Here it forms strong cross-links between structural 
proteins which makes up the cornified envelope, providing stability and strength.  
  
1.10 Aims and Objectives 
 The aims of this work are to investigate how the isoform specific expression of p63 influences the 
gene expression and regulation of multiple keratinocyte differentiation markers during differentiation. To 
achieve this, we want to investigate the marker expression in normal cases using monolayer culture of 
keratinocyte cell lines. This research includes culture of HaCaT cell lines alongside primary keratinocytes. 
The cells will be cultured for 13 days of differentiation with RNA extracted from cells at given time points.  
Gene expression analysis will be quantified via qRT-PCR using the TaqMan system. To further the 
investigation, we have decided to design and optimize siRNA-induced knockdown systems of the p63 
isoforms. We want to quantify the gene expression of the isoforms and gene markers in basal 
keratinocytes with the knockdowns and then look into how the expression of these genes change during 
keratinocyte differentiation in vivo.  
 There is a clear need for research into the roles of p63 isoforms due to a high level of conflict 
present in current research (Billant et al., 2016; Candi, Rufini, et al., 2006; Zhao et al., 2015). The main 
purpose of this study was to develop a technique to allow analysis of genes in basal cells, differentiating 
Figure 13: Left Panel: Speculated roles of p63 isoforms in epidermal 
differentiation pathways. ∆Np63 is demonstrated as regulating CHUK (IKK-
α) indirectly through Gata3. CHUK is shown to be regulated by ETS-1 also, 
which itself is regulated by TAp63 isoforms. Right Panel: P53 family 
members have varying roles from development (more predominantly p63) 
right through to DNA damage (predominantly p53). (Candi et al., 2007) 
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cells and cells at these stages with p63-isoform knockdown. By developing knockdown cells, the 
importance of individual isoforms can be examined in more detail, allowing downstream implications to 
also be investigated. The contrasting findings currently published is mainly due to the inability to 
differentiate between each isoform’s activities. These roles are yet to be uncovered fully due to the limited 
technology and techniques allowing specific studies. Herein lies the issue that is preventing the full picture 
of p63 isoform activity in keratinocytes being discovered.  
 The expected conclusions from this research is that there is further evidence that p63 has a dual 
role in keratinocyte differentiation, which arises from the differential expression of the two main classes 
of isoforms. The structural differences between the two classes give rise to varying functionality and are 
associated to different networking systems. Previous studies have identified TAp63 as a component 
present in terminal differentiation and hence we expect expression to be higher at the late stages of 
differentiation in keratinocytes. Through generation of knock down lines, there is an expectation that 
expression of other markers associated with p63 will be disrupted and this may lead to further 
downstream effects on expression at the gene level.  
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2.0 Materials and Methods 
2.1 Materials List 
 
Reagents and Components: 
Reagent Company/Supplier Order ID 
500 ml Filter System Corning 430758 
Adenin Sigma A2786-5G 
CaCl2 Sigma C2661-500G 
Cholera Toxin from Vibrio 
cholera 
Sigma 10236276001 
6 well plate Corning 355467 
Dimethylsulfoxid (DMSO) 
Rotipuran 
CarlRoth 4720.4 
Distilled water (DNase/RNase 
free) 
Gibco 10977-035 
DMEM Gibco 11960-044 
DMEM F12 (1:1) (1x) Gibco 21331-020 
DMEM Low Calcium Gibco  21068028 
Ethanol Absolute Acros Organics  445740010 
Fetal Bovine Serum (FBS) Gibco 10270-106 
Gentamicin (10mg/mL) Sigma G1272-100mL 
Human Epidermal Growth 
Factor (EGF) 
Sigma E9644-.2mg 
Hydrocortisone Sigma H0888-1G 
Insulin from Bovine Pancreas Sigma I1882-100mg 
Keratinocyte Basal Media 
(KBM) 
Lonza CC-3101 
Gold Keratinocyte Growth 
Media (KGM Gold) 
Lonza Catalog #: 00192060 
KGM Single Quot Kit Lonza CC-4131 
L-Glutamine 200mM (100x) Gibco 25030-123 
Lipofectamine 2000 Thermo 10696153 
OptiMEM Reduced Serum 
Media 
Gibco 31985062 
PBS pH 7.2 (1x) Gibco 20012-019 
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Penicillin-Streptomycin (P/S) Gibco 15140-122 
ProFreeze NAO/CD Freeze 
(2x) 
Lonza 12-769E 
Stealth siRNA Assays* Thermo Scientific *Details in Table 7 
Stealth Medium GC Negative 
Control 
Thermo Scientific 10143902 
TaqMan Fast Universal PCR 
Master Mix 
Applied Biosystems  4364103 
TaqMan Gene Expression 
Assays * 
Applied Biosystems  *Details in Table 6 
Trypsin EDTA 0.05% (1x) Gibco 25300-096 
Trypsin Inhibitor Soybean Gibco 17075-029 
 
Kits: 
Kit Compnay/ Supplier Order ID 
High Capacity RNA-to-cDNA 
Kit 
Applied Biosystems 4387406 
PureLink RNA Mini Kit Ambion 12183018A 
 
2.2 Probands and Ethical Approval 
Ethical approval for all work carried out in these studies were approved by the University of 
Huddersfield Ethics Committee. Any primary cells used for the purpose of this research were collected 
with the correct ethical approval from the clinic or laboratory from which they were taken. The cell lines 
used in keratinocyte differentiation were obtained from voluntary persons undergoing plastic surgery 
procedures. In all cases, samples were anonymized and denoted an alphanumeric code. Any donor was 
given full written notice about the study and a consent form was completed. As cells were of human 
origin, the cells were stored and handled under the Human Tissue Act and all relevant measures were 
observed.  
 The cells denoted HKc17, were obtained from Genoskin. This company has its own ethics that 
states they use real human skin to create skin models and samples for research purposes. The skin 
samples are derived from excess skin that is left over following surgical intervention. Genoskin follow the 
Declaration of Helsinki which outlines the ethics involved. The proband in this case was a 37-year-old 
female, obtained from the abdomen. Cell lines denoted HKc13 and HKc15 were samples obtained from 
abdomen biopsies of separate donors. These samples were obtained from the Huddersfield Royal 
Infirmary but donor information was not disclosed.  The HaCaT cells were donated as a gift from the 
German Cancer Centre.  
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2.3 Cell culture 
 All cell culture work was carried out in Class II laminar flow hoods that are suitable for BSL-1, 2 
and 3 materials. All general laboratory protocols for safe practice and work were observed including use 
of protective equipment. All cultures were at 37ºC and 5% CO2.  
2.3.1 HaCaT Cell Culture 
 HaCaT cells are immortalized human keratinocytes which have been used in many epidermal 
homeostasis studies. The have been evaluated as a model cell system to study normal and abnormal 
skin barrier function and gene expression work. These cells have been extensively used in the laboratory 
as a model system: mainly in comparative studies with human epidermal keratinocytes.  
 For the purpose of these experiments, cells were cultured in vitro in a 2D culture with low calcium 
media to maintain the cells at basal phenotype until ready for differentiating. Cells were from the 
laboratory stock: a gift from the German Cancer Research Center. Passage number 124 cells were plated 
in p10 (Falcon) dishes to allow growth and for cells to become confluent.  Keratinocytes grown in low 
calcium concentration below 0.03mM proliferate but fail to differentiate. Above 0.13mM calcium cells 
begin to differentiate into the stratified layers. In the laboratory, these conditions were mimicked by adding 
a calcium stock to the calcium-free media.  
Table 1: Media composition for calcium- free media for HaCaT cell culture 
 Once cells had reached 80% coverage of the plate, they were split using standard laboratory 
protocols into smaller vessels (p60- supplied by Falcon). Cells were plated at a density of 0.2 million cells 
per plate. The media composition is shown in Table 1. All components were added straight to the media 
in the state supplied by the company with exception of the Fetal Bovine Serum (FBS), which was filtered 
using Chelex100 to remove calcium ions from the serum.  
Media Component  Volume (250ml total volume) Concentration 
Calcium- free DMEM (GIBCO) 150ml 
 
Standard DMEM 1.8mM Ca2+ (GIBCO) 9ml 6% 
Fetal Bovine Serum (GIBCO) Chelex100 Treated 54.5ml 10% 
F12 Nutrient Mix (GIBCO) 25ml 0.3mM 
Glutamine (GIBCO) 5ml 4mM 
Pen/Strep (GIBCO) 2.5ml 100U/ml 
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 Once the cells in the p60 dishes were approximately 60-70% confluent the cells were introduced 
to the high calcium media. This media was prepared in the same fashion as the calcium-free media with 
the exception of calcium stock (Sigma Aldrich) added to a final concentration of 0.13mM (Table 2).   
 
Table 2: Media composition for the differentiation of HaCaTs in vitro containing high calcium 
concentration.  
Media Component  Volume (250ml total volume) Concentration 
Calcium- free DMEM (GIBCO) 150ml 
 
Standard DMEM 1.8mM Ca2+ (GIBCO) 9ml 6% 
Fetal Bovine Serum (GIBCO) 
Chelex100 Treated 
54.5ml 10% 
F12 Nutrient Mix (GIBCO) 25ml 0.3mM 
Glutamine (GIBCO) 5ml 4mM 
Pen/Strep (GIBCO) 2.5ml 100U/ml 
Calcium (CaCl2 stock- SIGMA Aldrich) 205.2µl 0.13mM 
 
 As gene expression throughout differentiation was investigated, cells were harvested at pre-
defined time points of every day from Day 0 to Day 7 and then Days 9, 11 and 13 were collected. This in 
total gave 11 time points from a two-week differentiation experiment. Day 0 samples were collected 
before the differentiation media was added to cells meaning these cells are still basal in phenotype. On 
each day of collection, the cells were washed with 1x PBS (GIBCO) to remove old media. Cells were 
then incubated for 10 minutes at 37ºC, 5% CO2 with 5x Trypsin EDTA (GIBCO) to dislodge cells from the 
plate. After the incubation with trypsin EDTA, 1x volume of serum-containing media was added to 
inactivate the trypsin activity. Gentle mixing and pipetting of the supernatant was used to collect any cells 
that were loosely attached to the surface. The total cell suspension was collected in a 15ml Falcon and 
centrifuged in a bench centrifuge for 4 minutes at 1000rpm. This process pelleted the cells, allowing the 
PAGE 27 
removal of the supernatant. The pellets were stored at -20ºC until required for downstream use. All this 
work was carried out using established protocols that the laboratory has optimized and tested previously.  
2.3.2 Keratinocyte Cell Culture 
 Culture of normal human keratinocytes was carried out in a similar fashion to the HaCaT culture. 
These cells were again maintained in a basal phenotype until ready for differentiation. Two comparative 
lines were used for these gene expression studies:  
 The first keratinocyte (HKLonza) line was a commercial line (Lonza). These cells are provided in 
a cryo-preserved state with each vial containing >500,000 cells. For this research, these cells in 
passage 4 were used.  
 The second line of keratinocytes used for this work were extracted from a skin sample supplied 
by Genoskin (HKc17). The sample was obtained from an abdomen section from a 37-year-old 
female. The cells used from this sample were at passage 2.  
Table 3: Media components for calcium-free KGM Gold media for human keratinocyte culture 
As the HKLonza were optimized for growth using KGM GoldTM Growth Media (catalogue number 
00192152), both cell lines were cultured using this media. This media is recommended for culturing 
human adult keratinocytes. The media components are all supplied in bullet form for addition to the basic 
Media Component (all supplied by Lonza) Volume (500ml total volume, to 
manufacturer’s recommendations. 
Reagent concentrations not disclosed) 
KGM Gold Media 500ml 
Hydrocortisone 0.5ml 
Transferrin 0.5ml 
Epinephrine 0.25ml 
Gentamicin Sulphate Amphotericin 1000 0.25ml 
Bovine Pituitary Extract 2.00ml 
Human Epidermal Growth factor 0.5ml 
Insulin 0.5ml 
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KGM GoldTM media. Addition of all the aliquots supplied means the media is prepared. The aliquots are 
shown in Table 3.  
For calcium-induced differentiation experiments in normal keratinocytes, HKc13 and HKc15 cells 
were used at low passage number. These cells were harvested on pre-determined days throughout a 21-
day period of differentiation. These cells were cultured as described an induced into differentiation by 
addition of calcium to the media. These cells were grown in standard KGM media (Lonza) as there was 
no need to culture these in Gold due to that fact they had not been optimized to grow in this media.  
As with the HaCaT culture, differentiation was induced by addition of calcium stock the media. 
The final concentration of calcium in the media was again made up to 0.13mM. Again, similar to the 
HaCaT experiments, differentiation was induced and cells were harvested at defined time points. The 
cells were harvested in the same way as described for the HaCaT experiments with one change to the 
protocol. As keratinocytes are more sensitive than the immortalized HaCaTs, the trypsin EDTA activity 
was inactivated by a trypsin inhibitor (ThermoFisher) rather than through addition of one volume of serum-
containing media. The days on which the cells were harvested at the same time points to allow for 
comparison between the cell lines. Once all cells from the differentiation were harvested, they were frozen 
at -20ºC until the RNA from these cells could be extracted.  
2.4 RNA Extraction and cDNA Synthesis 
 The total RNA was extracted from each of the cell pellets via the Ambion RNA Pure-link mini kit 
supplied by Life Technologies. This process involves a series of washes and spinning to isolate the RNA 
product before re-suspending in RNase-free water. The protocol supplied with the kit was observed 
throughout; with an additional DNase 1 treatment step added (Appendix 7.6). To begin, the cell pellets 
were washed with 0.6ml of Lysis buffer with 1% 2-mercaptoethanol to lyse the cell membranes. The same 
volume of freshly prepared 70% ethanol was added to the Falcon and the suspension was vortexed on 
a high setting until all precipitate was no longer visible. The liquid was passed through a spin cartridge 
containing a filter. Following each spin, the liquid was discarded and the filter kept. Following on, there 
were a series of washes with Wash Buffer 1. The samples were then exposed to a DNase 1 treatment 
where 3U/µL DNase 1 enzyme (Ambion) was added to the columns for 15 minutes at room temperature 
(Appendix 7.6).  This step removed any unwanted DNA in the samples that may interfere with the RNA 
quality and quantification. The samples were then washed twice with Wash Buffer 2 and finally eluted 
into 50µl of RNase-free water. The samples were stored at -20ºC for short-term storage. 
 The RNA quality and concentration was quantified on the Nanodrop 2000 (ThermoFisher) using 
standard settings for RNA analysis. Any RNA with low yield or quality were discounted from downstream 
work and cells were re-cultured to replace these poor yields. Purity readings of the 260/280 and 260/230 
ratios were used to assess the quality of the RNA yields at this stage. For RNA A260/280 ratio reading 
of ~2.0 is considered “pure” RNA and the secondary ratio of 260/230 should have expected values of 
between 2.0-2.2 for “pure” RNA. All samples had to fulfill this standard before use in cDNA synthesis. 
 To create the cDNA from the RNA samples, reverse transcription was carried out using the cDNA 
Synthesis kit from Applied Biosystems. This kit contains the MultiScribeTM reverse transcriptase enzyme, 
which allows for downstream applications including qRT-PCR. This protocol requires 2µg of RNA for 
every 20ul reaction. The protocol was followed as supplied with the reaction components as shown in 
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Table 4. A control sample without reverse transcriptase enzyme was used. The reverse transcriptase 
reaction mix was prepared on ice. The reverse transcription reaction was carried out at 37ºC for 60 
minutes followed by 95ºC for 5 minutes and then maintained at 4ºC permanently. Once produced the 
cDNA was quantified on the Nanodrop 2000 spectrophotometer and stored at -20ºC until required.  
Table 4: Components in the reverse transcription reaction mix to create cDNA from RNA 
Component Volume per Reaction (µl)- All volumes as per 
instruction from the manufacturer 
 
+RT -RT 
2x RT Buffer 10.0 10.0 
20x RT Enzyme Mix 
(containing 
MultiScribeTM reverse 
transcriptase) 
1.0 - 
Nuclease-free Water Quantity sufficient to 
20µl 
Quantity sufficient to 
20µl 
RNA Sample Up to 9µl (2ng) Up to 9µl (2ng) 
Total per Reaction 20.0 20.0 
 
2.5 Real-time PCR 
 Real time PCR was our chosen method for assessing the gene expression throughout 
differentiation. The system which was used for the purpose of this worked was the TaqMan system.  
 For the purpose of this research, TaqMan assays were ordered through ThermoFisher Scientific. 
Each assay was a predesigned assay that was recommended for this research type. All assays were 
tested in house either by the author. Previously in the laboratory, a different TAp63 assay (Hs00186613) 
was tested but the assay did not bind specifically and failed to amplify. Hs00978349 replaced this assay.  
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Table 5: TaqMan assays used for the purpose of this research. All probes labelled with FAM. 
Gene Product Number Function 
GAPDH Hs04420631 Housekeeping gene (Barber 
et al., 2005) 
RPL13A Hs04194366 Housekeeping gene (Mane et 
al., 2008) 
TAp63 Hs00978349 P63 isoform, transcription 
factor 
ΔNp63 Hs00978339 P63 isoform, transcription 
factor 
FLG Hs00856927 Terminal differentiation 
marker, structural protein 
KLF4 Hs00358836 Transcription factor, 
associated with terminal 
differentiation 
TGM1 Hs01070310 Enzyme involved with 
cornification process 
ETS-1 Hs00428293 Transcription factor, regulated 
by p63 
CHUK Hs00989497 Serine kinase, regulated by 
ETS-1 
 For the purpose of these experiments, the same label (FAM) was attached to each of the probes 
and all experiments involved only one gene of interest at a time. Benefits occur when a different label is 
assigned to the housekeeping gene than the gene of interest and ran in the same experiment. This was 
not employed here due to the small scale at which TAp63 expression has been reported in comparison 
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to the housekeeping gene and other genes of interest (Candi et al., 2007). This may have skewed the 
data obtained from this work.   
qRT-PCR is a technique which assesses relative gene expression as all quantification is relative 
to expression of a housekeeping gene; in this case GAPDH and RPL13A were used. GAPDH is a 
commonly used housekeeping gene used in cellular gene expression studies, as it is a ubiquitously found 
compound essential for step 6 of glycolysis to take place. Expression of GAPDH is thought to be relatively 
constant in cell types meaning normalization around GAPDH for other genes can give a relative 
expression reading (Barber et al., 2005). RPL13A is another housekeeping gene which is a ribosomal 
protein (Mane et al., 2008) and was used in this study as a second housekeeping to allow comparison 
between the relative expression data. Raw data from the qRT-PCR is manipulated to allow relative 
expression of each gene to be calculated.  
 The components of the TaqMan reaction were all supplied by Applied Biosystems and utilised in 
10µl reactions: 0.5µl 20xTaqMan Assay, 5µl 2x Real Time Buffer, ~400ng cDNA Template, RNAse Free 
water.  
 The raw data given out of a qRT-PCR experiment is the number of cycles of PCR needed in order 
to reach a threshold of fluorescence given off by the probes. These values are called Ct values and it is 
the raw amount of cycles needed. In each experiment, GAPDH and RPL13A were used as housekeeping 
genes for normalizing results. Each experimental run included triplicate technical repeats of each gene 
in each condition to allow for mean averages and standard deviations to be calculated. In addition, each 
experimental condition and gene was tested in triplicate in three biological replicates to increase reliability 
of the data. The mean Ct values from each of the experiments were then converted to ∆Ct values through 
normalization of the expression data to the housekeeping gene. The data was then assessed in 
comparison from basal and to the day of differentiation that the sample was taken.  The values obtained 
from this assessment are termed ∆∆Ct values. This value was obtained by subtracting the ∆Ct value from 
the day of differentiation from the value for day 0. A transformation using the equation 2-∆∆Ct allowed a 
fold increase of expression to be calculated. All data therefore was relative to housekeeping expression 
and a fold increase of expression based on basal cell expression. All standard deviations are calculated 
within each triplicate repeat and have been displayed as the error bars in the data.    
2.6 siRNA Knockdowns 
 In this project, we wanted to explore how knockdown of the p63 isoforms would affect gene 
expression of the other isoforms as well as marker genes. To do this we needed to develop a knockdown 
system that targeted each isoform specifically. As there was a need for this high specificity, design of the 
system required serious considerations on which technique would be most appropriate. The method we 
settled on was the transient knockdown system utilizing siRNAs. Once a system type was determined, 
the specific type of siRNA knockdown had to be finalized. The final system was the Stealth RNAi 
knockdown designed and supplied by Thermo Fisher scientific.  
 The design of specific siRNAs which targeted a single isoform with no cross reactivity presented 
a number of problems due to the high sequence similarity between the isoforms. As the TA isoforms 
contained a transactivation region which the ΔNp63 isoforms do not possess, we chose to target this 
area for an assay for TAp63 isoforms. This transactivation domain is at the 5’ end of the protein and is 
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encoded by the promoter at the most 5’ end in the TP63 gene. At the cDNA level, this region spans 214 
nucleotides that is identical between α, β and γ forms of TAp63. Despite this region allowing for 
discrimination between TA and ΔN isoforms, it did not allow for specificity between α, β or γ isoforms.  
 This led to examining the full alignments of the transcripts to identify regions of specificity between 
the isoforms. Another issue that arose from examining the alignments was that sequence identity 
between ∆Np63α and TAp63α was very high outside of the transactivation domain. This was the same 
for the β and γ isoforms. This again presented problems for specific design of the siRNA. The solution 
that was decided on was to design a number of siRNAs that identified collections of isoforms and compare 
expression when these knockdowns were applied.  
 The first siRNA assay that was decided upon was a general p63 knockdown. This assay was a 
pre-designed Silencer Select assay from Ambion (Cat# 4392420, Assay ID s229400). This general 
knockdown for p63 has been described in literature as a successful assay for general p63 knockdown. 
The second assay that was decided on was a Silencer Stealth assay based around the transactivation 
domain found in the TAp63 isoforms. This assay was specific for all TAp63 isoforms and was a 21nt 
sequence which identified from nucleotide 49 of the target sequence. The final assay was designed to 
knockdown all β isoforms including TAp63β and ∆Np63β isoforms. This assay was designed around a 
region specific to the β isoforms. This region spans 21nt from nucleotide position 1745 of the target 
sequence (Table 9 and Figure 14).  
Figure 14: Approximate location of siRNA assay targets. Blue arrow denotes TAp63 specific, pink arrow 
denotes p63-Beta assay and green arrow denotes design to knockdown all six of the main p63 isoforms. 
Figure displays exon structure of TP63.   
TP63 
TAp63 p63-Beta 
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As the TAp63 and Beta assays were highly specific, manual design had to be carried out, 
observing design requirements for optimal knockdown. These points included a 21-nucleotide sequence 
that started at two A residues where possible. Another requirement for optimal design involves a 3’ 
overhang that contains UU dinucleotide overhangs. It is recommended that G residues are avoided due 
to the likelihood of cleavage of the siRNA by RNase at single stranded G residues. Finally, an efficient 
siRNA knockdown system involves a 21-nucleotide sequence with 30-50% GC content. Avoiding 
stretches of more than 4Ts or As in the target sequence further increase specificity. All these 
requirements were first determined in 2001 and have been further verified and used throughout siRNA 
design from then on (Elbashir et al., 2001). 
Once received, the powdered siRNAs were suspended in 1000µl RNase-free water and tested to 
optimize working concentrations to allow for optimal transfection.  
2.6.1 siRNA Testing 
 To optimize the working concentrations of the three siRNA assays an experiment was designed 
to test three concentrations of each of the assays. The working concentrations for testing were 10pmol/μl, 
20pmol/μl and 30pmol/μlsiRNA. To test the siRNA assays, Human keratinocytes from Lonza at passage 
3 were used. The cells were cultured in KGM Gold without Gentamicin (as standard siRNA media is 
antibiotic free). The protocol for transfection using Stealth Select siRNAs suggest Lipofectamine 2000 
(ThermoFisher) as a transfection reagent. The protocol for transfecting these cells was followed as 
supplied by ThermoFisher with all volumes adjusted for culture of cells p60 cell culture plates.  
Figure 15: Target sequences for the siRNA assay, which were self-designed. Top panel is region 
targeted in the TAp63 assay. The bottom panel is the region targeted in the p63-Beta isoforms. Purple 
highlighting represents target region.  
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Table 6: siRNA sequences used for knockdown of TP63, TAp63 and Beta isoforms 
 Cells were cultured one day before transfection cells were plated in growth media without 
antibiotics such that the cells would be 30-50% confluent by the time of transfection. This confluency is 
suggested to avoid cell overgrowth. For transfection, an oligomer-Lipofectamine 2000 complex was made 
by diluting the siRNA in Opti-MEM Reduced Serum media (Applied Biosystems) and Lipofectamine 2000 
in Opti-MEM media. These two suspensions were combined to create the oligomer-Lipofectamine 2000 
complex. This complex was added to the cells and were incubated for 24 hours in a CO2 incubator at 
37ºC (Appendix 7.9). After 24 hours the cells were washed with 1x PBS and incubated with 5x trypsin 
EDTA for 5 minutes to detach the cells from the plates. The cells were pelleted and stored at -20ºC. RNA 
was extracted from these cells and cDNA was made as described previously. Gene expression analysis 
was carried out using qRT-PCR using procedure as described above. This analysis involved looking at 
expression of both p63 isoforms and ETS-1 as another marker to assess the percentage efficiency of 
each concentration. In addition, a Stealth RNAi negative control of scrambled siRNA sequences with 
medium GC content was used (Thermo Scientific, Catalog. No 12935300).  
  
siRNA 
Name  
Total p63 TAp63 isoforms Beta isoforms 
Sequence 
Format 
siRNA sequence siRNA sequence siRNA sequence 
Sense 
(5’-3’) 
GGAUGAAGAUAGCAUC
AGAtt 
UUGUUCUCCGUUCGUU
GAUaU 
GUCAGGAUCUGGCAAG
UCUga 
Antisense  
(5’-3’) 
UCUGAUGCUAUCUUCA
UCCgc 
AUCAACGAACGGAGAAC
AAUU 
AGACUUGCCAGAUCCU
GACaa 
GC 
Content 
38% Sense/ 48% 
Antisense 
38% Sense/ 38% Antisense 52% Sense/ 48% 
Antisense 
Modificati
on 
Silencer Select Silencer Select Silencer Select 
Pre-
designed
/ Custom  
Pre-designed Custom Custom 
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2.6.2 Isoform Knockdowns in Comparative Cell Lines 
 Once working concentrations for each of the siRNA assays were determined, an experiment to 
test how the knockdowns would affect differentiation were devised using normal human keratinocytes. 
Two cell lines were used; the Lonza keratinocytes at passage 4 and the HKc17 cells at passage 2. Four 
conditions were set up to test each of the assays along with negative control cells, using the medium GC 
content control. The cells were plated at 0.1 million cells per p60 plate and cultured for 24 hours until 
transfection day. These cells were cultured in KGM Gold without antibiotic. The period of differentiation 
for this test was carried out over 12 days, with cells harvested on days 0, 4, 8 and 12. On transfection 
day, cells were transfected as previously described in 2.2.1 and incubated with the transfection 
complexes for 24 hours. After 24 hours, according to the protocol, the transfection media can be changed. 
At this point, high calcium differentiation media, as described in 2.1.1, was added to the cells to begin 
differentiation. One p60 plate of each cell type and each assay were harvested using standard protocol. 
This process was repeated on days 4, 8 and 12 with all pellets stored at -20ºC until they were used for 
RNA extraction.  
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3.0 Results 
3.1 RNA Purification 
Before cDNA was made, the quality of RNA extracted from the cell pellets were assessed using the 
NanoDrop 2000. This assessed RNA quality along with the concentrations extracted. Any impure or low 
quality RNA was not included in experiments downstream. Table 7 demonstrates an example of the data 
obtained from the Nanodrop 2000 for HaCaT cells.  
Table 7: Example Nanodrop 2000 reading for RNA quality extracted from HaCaT cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Day of Differentiation RNA concentration (ng/µl) 260/280 260/230 
0 564.4 1.99 2.13 
1 659.0 2.05 2.04 
2 903.3 2.04 2.04 
3 843.0 2.02 1.97 
4 998.4 2.03 2.20 
5 710.8 2.02 2.07 
6 1081.6 2.01 2.12 
7 760.5 2.01 2.14 
9 872.8 2.03 2.06 
11 730.9 1.99 2.19 
13 516.5 1.96 1.97 
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3.2 HaCaT differentiation 
 The first way in which cell differentiation was tracked was with photographs of the cells taken 
when cells were harvested for RNA extraction. These photographs allowed assessment of the cell state, 
with morphological changes suggesting differentiation had occurred. All photographs were taken using 
an EVOS XL Core Imaging System (ThermoFisher) at 20x magnification. At day 0, before differentiation, 
the cells appear in a classical basal keratinocyte state, they are cobblestone like with bright, defined 
edges. The cells appear rounded and full. As differentiation progresses, the cells begin to lose the bright 
edges and start to flatten. At terminal differentiation, the cells become completely flattened with no clear, 
defined edges. The cells also seem to encroach into each other with large pockets of highly differentiated 
cells.  
 
Figure 16: Photographs taken of HaCaT cells taken at time points during calcium-induce differentiation. 
Top Left: Day 0, Top Centre Left: Day 1, Top Centre Right: Day 2, Top Right:  Day 4, Bottom Left: Day 
7, Bottom Left Centre: Day 9, Bottom Right Centre: Day 11 and Bottom Right: Day 13. 
 The differentiation process for these HaCaT cells was carried out over two weeks with cells 
collected on days 0,1,2,3,4,5,6,7,9,11 and 13. The genes that were assessed were both p63 isoforms, 
KLF4, FLG and ETS-1. The housekeeping genes used were both GAPDH and RPL13A. All experiments 
used TaqMan qRT-PCR and were completed in triplicate on three separate occasions.  
 The relative expression data obtained from the real time PCR experiments give some indication 
as to the mirrored nature of the expression of each isoform in differentiation. Looking at the expression 
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of ∆Np63 isoforms (Figure 17, Panel A), it can be seen that this isoform is not particularly over expressed 
in the early days of differentiation. However, as differentiation reaches around Day 4 expression starts to 
increase. This increasing 
trend continues through 
days five and six 
whereupon expression 
peaks about half way 
through the 2-week 
experiment. Beyond Day 
6, expression of ∆Np63 
isoforms decreases 
steadily, continually 
reducing all the way 
through to Day 13 when 
cells were no longer 
harvested.  
In contrast, the 
TAp63 expression (Figure 
17, Panel B) pattern looks 
different to that of the ∆Np63 
expression pattern. Like the 
∆Np63 expression in the 
early days of differentiation, 
TAp63 expression is 
relatively unchanged 
through to Day 6 of 
differentiation. At Day 7 of 
differentiation, expression of 
the TAp63 isoforms begins 
to increase, and keeps 
increasing through to Day 
11 of differentiation. This 
Figure 17: HaCaT differentiation results. A) ∆Np63 expression shows a steady increase in relative expression up 
until Day 6. Beyond Day 6 expression seems to decrease towards terminal differentiation at Day 13. B) TAp63 
expression appears to be low in the early days of differentiation up until around Day 7 when expression increases 
and continues to increase towards the final days of differentiation. GAPDH used as housekeeping in this case. Error 
bars represent Standard deviation. This data was published in Barragán Vázquez I, Lima Cunha D, Hockney S, Tang 
KY, Thomforde Kitson S, Eckl KM, Hennies HC, The role of p63 isoforms in the epidermal development as replicated 
in cellular models for normal human skin and genetic skin diseases. Presented at the 67th Annual Meeting of the 
American Society of Human Genetics, Orlando, Florida, USA, 2017 and presented at the BSID Annual Conference 
2018, London, United Kingdom 
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peak towards the latter stages of 
keratinocyte differentiation suggests 
a role for TAp63 isoforms in 
regulating the final steps of 
differentiation. These results come 
with restraints when assessing 
them, as again these data are 
relative to GAPDH and are from an 
immortalized cell line in HaCaTs. 
Comparison between the 
expression patterns of the two p63 
isoforms is seen in Figure 19. 
Around Day 5 or 6 in each of the 
expression profiles there appears to 
be a switch in expression whereby 
TAp63 expression levels begin to 
increase and ∆Np63 expression 
decrease.    
As for the other markers 
assessed in the HaCaT cell line 
differentiation, they followed other 
expression patterns.  
The transcription factor 
KLF4 has previously been 
implicated in regulating terminal 
differentiation (Segre et al., 1999). 
In our experiments in HaCaTs, 
expression of KLF4 did not show a 
particularly clear expression pattern 
with fluctuating expression in the 
Figure 18: Real time PCR results from the 
marker genes assessed during HaCaT 
differentiation. A) KLF4 expression has less 
of a clearly defined pattern of expression 
than the other markers however, expression 
peaks around days 7-9. B) Expression of 
ETS-1 shows a gradual increase in 
expression throughout the differentiation 
process with peak expression being towards 
terminal differentiation. C) Filaggrin is a 
terminal differentiation marker and this 
expression profile matches that of a terminal 
differentiation marker with peak expression 
being in the later days. Error bars represent 
standard deviations.   
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first week of differentiation. However, beyond Day 6, a large peak of expression is seen and a relatively 
high expression level is maintained from then to the final days tested, with a small decrease after Day 7. 
This supports the idea of KLF4 being involved in terminal differentiation.  
Another transcription factor ETS-1 showed a steady increase as differentiation progressed with a 
small decrease between days 6-9 but the general increasing trend continues right up until Day11. This 
transcription factor has been identified as p63-regulated and has been implicated alongside CHUK as 
being involved of progressing differentiation in keratinocytes (Candi et al., 2007).  
Finally, the terminal differentiation marker FLG expression was as expected (Zeitvogel et al., 
2017), increasing steadily throughout differentiation with peaks occurring at days 11 and 13. At the early 
stages, the expression levels are low, around the baseline relative expression. It is only around Days 5, 
6 and 7 where an increase in expression can be observed, peaking at approximately 15 times higher 
expression than Day 0.  
 These expression profiles matched what was hypothesized given what was previously reported 
into the function of each of these markers. To reinforce this data, we differentiated normal keratinocytes 
in order to have a comparative line.  
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Figure 19: Expression for both p63 isoforms during calcium-induced differentiation in HaCaT cells. 
Expression of both isoforms is low at the early stages of differentiation with ∆Np63 expression peaking early 
at Days 5-6. TAp63 expression has a converse pattern peaking later at Day 11 after ∆Np63 expression 
begins to decrease.  
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3.3 HK Differentiation  
  Experimentally the differentiation of 
the normal human keratinocytes was similar to 
that of the HaCaTs with only the culture media 
being different. The cells used in this work were 
low passage normal human keratinocytes 
denoted as HKc13 and HKc15. The cells grew 
well with basal cells exhibiting the typical 
morphological features such as bright, defined 
edges and full appearance. The morphology 
changed through differentiation, similar to how 
the HaCaTs changed with cells flattening out 
with less defined edges. For the purpose of this 
analysis, we looked at expression of the p63 
isoforms, FLG, KLF4 and TGM1. The results 
shown are from experiments where GAPDH was 
used as the housekeeping. 
  
  
 
 
Figure 20: Photographs of Lonza keratinocytes 
throughout differentiation. Top Panel- basal cells, 
before addition of calcium to media. Middle Panel- 
cells after 4 days of differentiation. Bottom Panel- 
cells after 10 days of differentiation. 
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 When the p63 isoforms were examined through qRT-PCR, we observed a similar pattern of 
expression for ΔNp63 isoforms in each cell line. The amount of increase in expression relative to Day 0 
cells was small compared to TAp63. This was consistently seen in both HKc13 (Figure 21, Panel A) and 
HKc15 cells (Figure 21, Panel B). In both cell lines, peak expression for ΔNp63 was observed between 
0
10
20
30
40
50
60
70
80
0 1 4 7 8 11 12 14 16 21
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 2
-Δ
Δ
C
t
Day of Differentiation
HKc13 TA vs ΔN
TAp63 ∆Np63
0
20
40
60
80
100
120
140
160
0 1 4 7 8 11 12 14 16 21
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 2
-Δ
Δ
C
t
Day of Differentiation
HKc15 TA vs ΔN
TAp63 ∆Np63
Figure 21: Real time PCR data from normal human keratinocytes HKc13 and HKc15. Differences in pattern 
of expression for TAp63 was observed between the two cell lines with ΔNp63 exhibiting small but consistent 
changes in expression. Error bars represent standard error.  
PAGE 43 
Days 8 and 11. With this being said, the relative fold change in expression was low in comparison to the 
TAp63 isoforms, with expression change remaining below 20-fold. As for TAp63, there was some conflict 
in the results obtained with inconsistencies between the expression profiles between cell lines. HKc13 
cells exhibited a strong peak of expression in the early stages of differentiation between Days 1 and 4. 
Beyond these days, there was a lower fold increase on Day 0 expression before a peak was seen at Day 
16. In contrast, the HKc15 cells showed a steady increase in expression of TAp63 throughout 
differentiation, peaking around Day 16.This peak is consistent with the peak seen in the HKc13 cells.  
 TGM1 as a terminal differentiation marker would be expected to have peak expression towards 
the later days of differentiation. This pattern was seen in the HKc13 cells (Figure 22, Panel A) and to 
some extent, the HKc15 cells (Figure 22, Panel B). The clear curve of increasing magnitude of 
expression in HKc13 cells fits with TGM1’s role in terminal differentiation. The pattern seen in HKc15 
cells is more flattened with expression staying reasonably consistent throughout differentiation. Like 
TGM1, we expected FLG expression to peak late also. Again, in HKc13 cells we saw this curve of steadily 
increasing expression, with peaks beyond Day 11 through to Day 16. Similarly, to the TGM1 expression, 
FLG expression in the HKc15 cells was flattened however, a significant peak around Day 11 was 
observed.  As for KLF4, the expression profiles are not as smooth with peaks and troughs of expression 
throughout each cell line. However, in both lines the highest fold increase was observed towards terminal 
differentiation (Figure 22).  
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Figure 22: Relative expression of TGM1, KLF4 and FLG- three marker genes used for study of the 
differentiation. TGM1 and FLG are terminal differentiation markers while KLF4 is a transcription factor 
involved with regulating steps leading to terminal differentiation. Error bars represent standard error. 
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3.4 Knockdown of p63 isoforms test results 
 Given the data obtained from the experiments with HaCaTs and human keratinocytes, we wanted 
to induce p63 knockdowns using the systems described previously on basal cells. The siRNA assays 
needed to be tested to calculate optimal working concentrations. To evaluate each assay, three 
concentrations of siRNA were tested- 10pmol/μl, 20pmol/μl and 30pmol/μl. For each of these 
concentrations, both the p63 isoforms’ expression was tested, using GAPDH as the housekeeping. These 
experiments were used to calculate percentage knockdown for each of the siRNA assays. The negative 
control in this case appeared to be approximately 2.5 times more expressed than the normal HKs. These 
cells were included as it is a representation of the experimental process without the siRNA assays. This 
point was used as a comparison for expression as it takes into account the experimental process’ impact 
on the cells and their respective expression as a result of this treatment. Normal cells, which have not 
been exposed to Lipofectamine- driven transfection methods, may express differently to those that have.  
 As seen in Figure 23, the varying amounts of each assay had different effects on isoform 
expression in basal keratinocytes. When cells were exposed to the total p63 knockdown assay, small 
decreases in isoform expression occurred. At 10pmol/μl siRNA, expression of ∆Np63 reduced a small 
amount compared to the normal Human keratinocytes, but a large amount in comparison to the negative 
Figure 23: Relative expression of p63 isoforms under the respective knockdown assays. When total p63 
was knocked down, expression of ∆Np63 was decreased when 30pmol/μl siRNA was added, TAp63 
expression increased with a small margin at lower concentrations. When TAp63 was knocked down, 
levels of TAp63 expression did decrease at 10pmol/μl RNA and 30pmol/μl siRNA. ∆Np63 expression 
increased when siRNA concentration was at 20pmol/μl. When p63-Beta was knocked down, the 
expression of both isoform, types decreased at all siRNA concentrations. Medium GC content negative 
siRNA control used as negative control. Error bars represent standard error.   
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control cells. At 20pmol/μl siRNA, the change in ∆Np63 expression is very similar, however at the higher 
concentration of 30pmol/μl siRNA, a very large decrease in expression is observed from the negative 
control cells. This decrease of approximately two fold suggests this concentration was the most effective 
at knocking down total p63. This is supported by a large decrease in expression of TAp63 occurring when 
30pmol/μl siRNA was used. Small decreases on the negative control cells was observed when 10pmol/μl 
and 20pmol/μl siRNA was used in this context.   
 When cells were exposed to the TAp63 knockdown, expression patterns of each isoform was 
different. At 10pmol/μl siRNA, there were decreases in both the expression of ∆Np63 and TAp63. At 
20pmol/μl siRNA, a different pattern is exhibited with very limited decreases in the expression of ∆Np63 
and a lesser decrease in the TAp63 compared to 10pmol/μl siRNA. At 30pmol/μl siRNA, again a decrease 
in both the isoforms’ expression is seen. The largest decrease was when only 10pmol/μl siRNA was 
used.  
  
Finally, when the beta isoforms were targeted for knockdown, there was a large decrease in 
isoform expression when all concentrations of siRNA were used. The optimal concentration for 
Figure 24: Percentage knockdown for each of the three assays at three concentrations. TP63 assay- knocked down 
ΔNp63 isoforms at an efficiency between 50-60% whereas TAp63 isoforms appeared to have a small increase in 
expression. TAp63 assay- 60% knockdown for ΔNp63 when 10 and 30pmol/μl siRNA was used. TAp63 expression 
had approximately 60% knockdown. Beta knockdown- percentage knockdown of ΔNp63 isoforms was between 55% 
and 75% dependent on concentration of assay used. TAp63 knockdown was less efficient achieving a maximum of 
30% knockdown. Error bars represent standard error. 
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knockdown when analyzing the different concentrations appeared to be when 20pmol/μl siRNA was used. 
As the Beta isoforms appear in both a ∆Np63 form and the TAp63 form, as expected the expression of 
both these isoforms were affected.  
 As all of these tests used relative expression compared to GAPDH and negative control cells, 
another level of assessment was employed to determine the most affective concentration of assays. This 
was achieved by calculating the percentage knockdown in each situation (Figure 24) relative to the 
negative control line expression.  
 The efficiency of each of the assays at each of the different concentrations varied considerably. 
When cells were exposed to the TP63 assay and analysis focused on ∆Np63, 50 and 20pmol/μl siRNA 
gave percentage knockdown of just under 50%. When the concentration of siRNA was increased to 
30pmol/μl, the efficiency of the knockdown increased to 70% knockdown. This is the most efficient of the 
three concentrations in this case. As for analysis of the TAp63 isoforms, the assay appears to cause a 
small increase in expression. This increase is less than 10% in all concentrations. This may suggest a 
problem with the specificity of the assay in that it only targets ∆Np63 isoforms or that there was a 
methodical problem with the experimental process.  
 When examining the efficiency of the TAp63 knockdown, there is variation between the different 
concentrations of the assays. At 10pmol/μl, the efficiency of the knockdown for ∆Np63 was approximately 
65%. There was a similar efficiency when 30pmol/μl siRNA was used with 35-40% efficiency when 
20pmol/μl was used. This presents an issue over specificity as the TAp63 assay should have no effect 
on the expression of ∆Np63. As for TAp63 knockdown efficiency, at 10pmol/μl there is 60% knockdown, 
20pmol/μl there is 50% knockdown and at 110pmol/μl, there is 65% knockdown. Much like the TP63 
assay, the highest concentration of siRNA assay was the most efficient in regards the TAp63 isoforms.  
 The efficiency of the p63-Beta assay had a large contrast between the two p63 isoforms. The 
efficiency of the ∆Np63 knockdown ranged from 55% (10pmol/μl) to 75% (20pmol/μl). These efficiencies 
are high in regards to ∆Np63 suggesting that Beta isoforms account for a large proportion of the 
population of ∆Np63 in basal cells. In contrast, the efficiencies for TAp63 with this assay was much lower. 
At 10pmol/μl siRNA, the efficiency of the knockdown was below 10%. When 100 and 30pmol/μl siRNA 
was used the efficiency increased but still was only at 30%. This may suggest that TAp63-β isoforms 
account for a much smaller proportion of TAp63 isoforms in basal cells. Alternatively, this may suggest 
that the assay is not specific enough to target TAp63-β.  
 This test raised some questions about the effectiveness of each of the assays on each of the 
isoforms. In the majority of cases there was a percentage knockdown, however these percentages were 
low compared to the manufacturers’ claim of between 60-80% knockdown efficiency. As two of the assays 
(TAp63 and p63-Beta) were self-designed, it may suggest sequences were not as efficient as they could 
be. To validate if these percentage efficiencies were correct, another test was designed to use all three 
assays at the most efficient concentrations. This test would include analysis of basal cells but also 
differentiated cells to assess if differentiated cells allow for knockdowns that are more efficient.   
3.5 HK Lonza vs HKc17  
 To carry out this work, two normal keratinocyte cell lines were chosen to allow for comparative 
analysis. In addition, as the Lonza cells were commercially sourced and produced, use of a cell line 
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extracted from a skin sample carried out in the lab was used to see if there was variation in expression. 
The morphology of the cells during this experiment appeared to be not as expected, with the cell shape 
being flat and looking dead. With the RNA extraction, this was confirmed as the cells not being viable for 
use in qRT-PCR due to poor RNA quality. With that being said, the cells obtained on Day 0 had high 
quality RNA from the extraction so these were used for qRT-PCR analysis.  
Table 8: Example of RNA extraction data from HKLonza and HKc17 after knock down and differentiation 
Cells RNA 
Concentration 
(ng/μ) 
A260/280 A260/230 
HKLonza Day 4 TAp63 
KD 
1.8 2.52 0.24 
HKLonza Day4 Neg Ctl  5.1 1.70 0.30 
HKLonza Day 4 TP63 KD 8.9 1.74 0.16 
HKLonza Day 4 Beta KD 1.2 2.34 0.33 
HKc17 Day 4 TAp63 KD 15.2 2.08 2.27 
HKc17 Day 4 Neg Ctl  5.4 1.79 0.16 
HKc17 Day 4 TP63 KD 4.6 1.58 0.37 
HKc17 Day 4 Beta KD  9.9 2.64 0.30 
 
  
With Day 0 cells from both cell lines and with each knockdown assay, basal (pre-differentiated) 
cell analysis could be carried out. This gave a comparison between two keratinocyte lines and between 
each assay. The fact that the non-differentiated cells had high quality RNA product, it suggests that 
differentiation may have disrupted the cell growth once p63 knockdowns had been introduced. Time 
restraints prevented repeating this process but this is the next step to optimize and investigate in order 
to allow for a full differentiation timespan with each of the knockdowns incorporated.  The RNA extraction 
from these cell pellets produced limited to no RNA, and any which was obtained was low quality. This 
meant that the only viable RNA from this experiment was that obtained from the basal cells. These cells 
included the knockdowns but were not differentiated.  
 For the purpose of analyzing expression in basal cells when the knockdowns were in place, qRT-
PCR was carried out using assays designed for each isoform and ETS-1 as an independent marker. Like 
other knockdown experiments, a medium GC negative control was used but in this case was used to 
normalize the relative expression (Figure 25).  
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When ΔNp63 was examined in HKc17 (Figure 25, Panel A) it appeared that its expression was 
very little when the total siRNA assay was added with a slight increase in expression when Beta isoforms 
were knocked down with no significant change when TAp63 knockdown was completed. In The HK Lonza 
cells (Figure 25, Panel D) a small decrease was seen when either total p63 or Beta isoforms were 
knockdown however, there was an overexpression of ΔNp63 when TAp63 was knocked down. When 
TAp63 expression was examined in HKc17 cells (Figure 25, Panel B) there was no expression when 
the total p63 siRNA was added however there were increases in expression when the assay designed to 
knock down TAp63 was involved. A large increase in expression of TAp63 was observed when Beta 
isoforms were knocked down. In Lonza keratinocytes (Figure 25, Panel E) TAp63 expression increased 
when total p63 and Beta isoforms were knocked down with little-to-no change when the TAp63 
knockdown was introduced. ETS-1 expression in HKc17 (Figure 25, Panel C) and HK Lonza (Figure 
25, Panel F) followed a similar pattern with small increases in expression when any of the knockdowns 
were introduced with Beta isoform knockdown resulting in the highest level of ETS-1 expression.   
Figure 25: qRT-PCR results from basal (non-differentiated) cells with knockdowns present in two cell lines- 
HKc17 and HK Lonza, examining expression of the two p63 isoforms and ETS-1. Error bars represent standard 
error. 
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Comparison between the two cell lines presented some interesting findings with different levels 
of expression of each of the p63 isoforms depending on which cell line the knockdowns were carried out. 
When ∆Np63 isoforms were examined using qRT-PCR in HKc17 cells, there were significantly lower 
levels of ∆Np63 when total p63 was targeted with the siRNA. When the assay designed to target TAp63 
isoforms was used in these cells a small decrease in ∆Np63 was observed. Finally, when p63- Beta 
isoforms were targeted for knockdown, an increase in ∆Np63 expression was seen. In comparison, when 
∆Np63 was examined using HK Lonza cells as the model system, a different profile of expression was 
seen. When these cells were exposed to the total p63 knockdown siRNA assay, there was a small 
decrease in expression of ∆Np63 compared to the negative control cells. When the TAp63 knockdown 
was introduced, ∆Np63 expression had a large increase compared to the control cells suggesting 
knockdown of the TAp63 isoforms allowed ∆Np63 isoforms to take over in basal cells at least. Much like 
when the total p63 assay was introduced into these cells, when the Beta isoform knockdown was 
introduced a small decrease in ∆Np63 was observed.  
 As for TAp63 expression in the HKc17 cells, there was a small issue surrounding data collection 
when the total p63 siRNA was added to the cells as two out three triplicate repeats resulted in an 
undetermined result. This may be due to an experimental error as qRT-PCR is a very sensitive technique 
or the total p63 knockdown may have disrupted the RNA of the TAp63 isoforms in some way. As for the 
other two assays, increases in expression of TAp63 were seen with a small increase when TAp63 
knockdown was introduced and a much larger increase seen when Beta isoforms were targeted. With an 
increase in expression in TAp63, when a knockdown specifically designed to knockdown these isoforms 
was introduced, suggests a non-specific interaction between the siRNA assay and the target. The 
expression of TAp63 in HK Lonza cells increased significantly when total p63 was knocked down, with a 
similar level of expression when the Beta isoforms were targeted. As for TAp63 expression, when the 
siRNA designed to knock TAp63 isoforms down was introduced, showed little to no change on the 
negative control cells, again suggesting the knockdown assay was not specific.  
 When ETS-1 was examined in each of these cell lines exposed to the various knockdowns (HKc17 
and HKLonza), a similar pattern of expression change was observed with small increases in expression 
in all cases. The largest increase in expression of ETS-1 was seen when the Beta isoforms of p63 were 
targeted for knockdown. This may suggest the Beta isoforms of p63 have a repressive role over ETS-1 
expression, which when removed allows for higher levels of expression. These genes were selected as 
the cells investigated were basal cells and we were not assessing differentiation at this point. To continue 
this work differentiating the cells and assessing differentiation markers would provide deeper 
understanding.  
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4.0 Discussion 
 The transcription factor p63 is a master regulator of a number of key processes involved in the 
correct development of the epidermal layers. The gene encodes multiple isoforms each of which play 
different roles in these events that determine the epidermis formation (Soares & Zhou, 2018). Information 
regarding the particular roles of each of these isoforms has been only partly investigated with a lot more 
research into this area required. The difficulty with working at an isoform level is the sequence homology 
between each of the species creating issues with siRNA or even other systems. Other systems which 
could be used for knock out or knock in experiments is CRISPR- Cas9 or shRNAs, however currently 
there are no commercially available guide strand RNAs available with specificity required to differentiate 
between each isoform. In addition, there are currently limited options when looking at the protein 
expression level with only a handful of commercially available antibodies specific for TAp63 or ∆Np63 
and none that identify particular isoforms. Antibodies for pan p63, TAp63-specific and ΔNp63-specific 
have been acquired and are in the early stages of being optimised. Again, we were unable to use α, β or 
γ- specific TaqMan probes as these have not been designed and are difficult to design due to high 
sequence homology amongst the isoforms that would lead to non-specific effects. Working with assays 
targeting TAp63 or ∆Np63 isoforms is enough to identify trends in expression of these isoforms but for a 
detailed interrogation of α, β or γ forms, individually either more specific assays or alternative methods 
are required.   
When designing siRNA assays for the experiments described, there were a number of issues 
encountered in order to design a specific assay. The sequence homology between the isoforms is high 
and regions that are specific to the TAp63 isoforms are identical. The transactivation domain present in 
all TA isoforms has an identical sequence which makes it ideal for differentiating between TAp63 isoforms 
and ∆Np63 isoforms but cannot be used for specific targets within the TAp63 subclass (α, β and γ). To 
further complicate matters, the regions present which differentiates the TAp63-γ from TAp63-α and β is 
identical in sequence to the region that differentiates ∆Np63-γ from ∆Np63-α and β. The same principle 
applies to the regions which define the α and β isoforms. This resulted in not being able to develop siRNA 
assays that particularly targeted one of the six main isoforms of p63. To circumvent this issue, we chose 
to look specifically at different assay types and then collate the information obtained to elucidate what is 
happening to gene expression when cells are exposed to different p63 knockdowns. The first assay for 
total p63 would give a complete coverage of p63 knockdown which would allow generalizations over 
p63’s influence on gene marker expression. By using a general knockdown, all six of the main isoforms 
are targeted via a conserved region that is common in all isoforms (Figure 23).     
When the HKc17 and HKLonza cells were cultured for the purpose of testing these assays, there 
was irregular growth and morphology observed. The RNA quality obtained from these cell samples was 
low in concentration and low in quality. However, we obtained high quality RNA from the basal cells and 
these were used for comparative analysis. The results, which we saw from this experiment, may be down 
to the fact that p63 activity was removed from these cells. On the molecular level, p63 knockdown can 
genes that arrest the cell cycle such as p21. This halt on the cell cycle may explain as to why the cells 
we cultured appeared to be not growing. Additionally, knockdown of p63 can also downregulate genes 
associated with positively regulating proliferation, whilst upregulating genes associated with negative 
regulation of proliferation. Finally, genes which are important for epidermal differentiation, including Perp 
and K14 are downregulated when p63 is knocked down (Romano et al., 2007). Another explanation that 
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may describe how the cells we collected were not viable, may be due to p63’s role in regulating the 
glycolytic metabolism cascades within keratinocytes. Hexokinase 2 and 6-phospho-2-kinase/fructose-2, 
6-bisphosphate 3 (Hamanaka & Mutlu, 2017; Viticchiè et al., 2015) are p63 regulated and removal of p63 
sees decreased expression of these proteins.  The removal of the normal p63 activity in these cases may 
suggest as to why the cells failed to be viable beyond the first day of differentiation. The proliferative 
potential of the cells prior to introduction of the differentiation agents may have led the cells out of the cell 
cycle and towards cell death. Once the differentiation media was added, 24 hours later, the cells may 
have already lost the capability to differentiate either through loss of expression of Perp and K14 or 
through dysregulation of the glycolytic pathways.  
4.1 TAp63  
Beyond the general knockdown, a more specific approach, which we decided upon, was to look 
at detail into the TAp63 isoforms. We chose TAp63 as this isoform has been rarely talked about previously 
in the literature in the context of keratinocyte differentiation. ∆Np63 is widely reported as the most 
populous isoform in keratinocytes throughout the epidermis, accounting for 99% of total p63 presence 
(Candi et al., 2007). With that being said, TAp63 accounting for 1% of p63 population suggests there is 
a role for this isoform. To support this notion that there is some small level of TAp63 present in 
differentiating keratinocytes, the experimental data obtained from our experiments in differentiating 
HaCaT cells reinforced this. As shown in Figure 25, we observed a peak in TAp63 expression on Day 
11 of differentiation. At this stage, the cells are in the later stages of differentiation. Before Day 11, the 
expression of TAp63 is low, with it staying low right up until after Day6. At this point, the expression levels 
climb to its peak at Day 11 before dropping slightly. The increase in expression of TAp63 suggests this 
is the period in the differentiation process when it is important. As a transcription factor, TAp63 must be 
regulating some of the steps involved in either the structural changes or morphological changes 
associated with terminal differentiation. Furthermore, the expression pattern of the ∆Np63 appears to 
mirror that of the TAp63. When TAp63 expression is at its lowest between Days 4 and 6, expression of 
∆Np63 peaks at this time. This peak is after low levels of expression in the very early stages of 
differentiation and beyond the peak, levels drop as the cells progress towards terminal differentiation.  
The expression profiles between the two normal human keratinocyte cell lines for ΔNp63 were 
consistent; however, there were variations when TAp63 was examined. In Hkc13 cells, a large peak was 
seen in the early stages of differentiation that is not consistent to data we have from HaCaT cells and 
HKc15 cells. This may have appeared due to experimental error. Discounting this peak, there was an 
expected profile of expression with peak expression occurring on the days when terminal differentiation 
is expected. This again provides weight to the idea of TAp63 playing a role in regulating terminal 
differentiation.  
In literature, there has been suggestions that there are dominant negative relationships between 
the p63 isoforms much like the dominant- negative relationships between the rest of the p53 family (Billant 
et al., 2016). This notion was arrived upon by the observation that since ∆Np63 lacked a transactivation 
domain; it acted as a dominant negative towards TAp63. More recently, this theory has been changed 
significantly with discovery of an additional transactivation domain at the C-terminal end of the ∆Np63 
isoforms (Duijf et al., 2002; Marcel et al., 2012). With this being said, the mirrored expression of the 
isoforms during differentiation, may be due to more dominant isoforms downregulating expression of less 
dominant forms. As differentiation progresses, the dominance of each isoform may flip, allowing for the 
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characteristics of the expression patterns seen. Transcription networks are complex and it is very unlikely 
that only the interplay between the isoforms is responsible for the changing expression in differentiating 
cells. Vast networks of transcriptional control allow for the correct progression through differentiation with 
many markers involved including the likes of KLF4 and ETS-1.  
 Interestingly, some research into TAp63 expression in keratinocyte differentiation has been 
carried out recently with findings being conflicting not only to data obtained in our study but with other 
studies. When TAp63α is expressed and ΔNp63 is not, induction of Keratin 5 and 14 occurs. These 
keratins are allowing stratification of keratinocytes. TAp63 null mice have demonstrated, interestingly, 
that this isoform is dispensable for the development of the epidermis (Su et al., 2009). Candi et al (2007) 
suggests that TA isoforms play a role in the terminal differentiation steps in mice epidermis and TAp63 
protein has been found in the mature epidermis- despite ∆Np63 being the main isoform found. This paper 
also mentions a study in which TAp63 was observed to induce pluristratification in single layered lung 
epithelium and to block skin differentiation (Koster et al., 2007). These findings suggest a role for TAp63 
in early stages of differentiation however; we are only seeing peak expression towards the later stages 
of differentiation. Conversely, in the study carried out by Candi et al (2007), they conclude that TAp63 
expression is found later in the differentiation process, playing a role in the steps preceding the formation 
of the cornified envelope, regulating ETS-1, CHUK and other genes involved. These findings support the 
data obtained in our work, with peak TAp63 appearing at the latter stages instead of early in the process.  
 To investigate TAp63’s role further in terminal differentiation, development of knock out skin 
models could be developed without the active TAp63 isoforms. The barrier function of the skin models 
produced could provide some insight into if the expression of the proteins associated with barrier function 
are disrupted due to TAp63 activity being removed or reduced. Additionally, comparison between mRNA 
data and protein data for TAp63 expression in the later days of differentiation could reinforce roles for 
these isoforms.  
 Another study carried out recently identified no role for TAp63 in the whole process of keratinocyte 
differentiation and this was verified through mRNA and protein expression work (Kouwenhoven et al., 
2015). This highlights the difficulty of analyzing p63 at an isoform level. Due to the high level of homology 
and the limited specific technologies to study at the isoform level, it complicates analysis and evaluation 
of work. A clear need for design of specific antibodies and primers to allow for study at this level is of high 
importance due to the role of p63 in not only development but also disease and cancer. TAp63 isoforms 
only account for approximately 1% of total p63 expression in keratinocytes creating further complications 
as ∆Np63 expression may cloud TAp63 patterns due to the sheer scale difference between the two. 
TAp63 regulation is another area that is interesting to look into as the regulators of TAp63 can 
allow for predictions on its roles. The NF-κB transcription factor mediates a multitude of cellular processes 
including growth, differentiation and apoptosis. TAp63 has been demonstrated to be a transcriptional 
target for the NF-κB complex through co-transfection methods (Wu et al., 2010). The conclusion drawn 
from this research was that TAp63 negatively regulates cellular growth and activation of NF-κB can arrest 
cell growth by mediation through TAp63, however the role of NF-κB in epidermal differentiation, if there 
is any, is still unknown. 
 A study in 2008 identified that in p53-mutated HaCaT cell lines TAp63-α was induced with the 
upregulation of GDF15 (Growth differentiation factor 15) (Ichikawa et al., 2008). They demonstrated 
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through siRNA knockdown of endogenous TAp63 that there was a reduction in the expression of GDF15. 
GDF15’s role is not entirely certain however, it appears to play a role in controlling inflammatory pathways 
along with roles in apoptosis and cellular growth. It has also been implicated as a prognostic protein in 
cancer (Wallentin et al., 2013). This study identified TAp63-α as being present in earlier stages of 
differentiation with upregulation appearing as soon as 12 hours after differentiation was induced. They 
noted an increase in the beta isoform but a downregulation of the gamma form. They verified this finding 
through protein assays, identifying TAp63-α as being readily found in proliferating HaCaT cells but was 
induced once differentiation stimuli were added. They showed in a time-dependent manner GDF15 was 
expressed in concordance to the upregulation of TAp63-α. A siRNA knockdown of TAp63 demonstrated 
a marked reduction in GDF15 suggesting a relationship between the two.  
 Not only does this highlight the complexity of the transcriptional networks involving p63, it 
demonstrates a role for TAp63 in earlier stages of differentiation opening up a new aspect of TAp63 
activity that has rarely been investigated. It is possible that there are significant roles for TAp63 
throughout the differentiation process, and not only in the early stages of epidermal commitment or 
terminal differentiation that have been previously reported.    
 With this being said, the preliminary results obtained in our study suggest a role for TAp63 in 
terminal differentiation that needs to be further investigated. To verify the activity of TAp63 isoforms at 
this stage, the knockdown procedure needs to be optimized and increased in specificity to allow analysis 
of downstream marker expression. This may mean a permanent knockdown system, instead of the 
transient knockdown siRNAs, with options including CRISPR or shRNA systems. This would allow for a 
single knockout line of cells to use for gene expression or protein expression analysis. Beyond this, 3D 
skin model culture could be used to assess the structural organization and morphology when TAp63 is 
not present.  
4.2 ∆Np63  
As for ∆Np63, analysis is much easier to assess due to the scale of expression of the isoforms in 
differentiation. This is reflected in the quantity of literature surrounding the role of ∆Np63 in keratinocytes. 
∆Np63-α is an isoform that is strongly expressed at the basal layer where the epithelial cells with the 
highest clonogenic and proliferative capacity reside. Previous research has given indications that these 
forms are required to maintain the proliferative potential (Truong et al., 2006).  The majority of current 
work agrees that ∆N forms are the major functional isoform in epithelial tissues. Phenotypes in ∆Np63 
knockout mice support this notion as they exhibit similar defects that mice lacking all p63 isoforms show 
(Soares & Zhou, 2018).  
We observed that the peak of ∆Np63 expression in HaCaT cells was around Day 5 of 
differentiation, supporting the idea that the ∆N isoforms are key for maintaining the cells in their basal 
state but also for regulating the progression through the early stages of differentiation. We also observed 
that when the general siRNA assay for total p63 was introduced into the HKc17 cells and qRT-PCR 
targeted ∆Np63, that there was a large decrease in expression of ∆Np63. This may suggest that the 
majority of p63 found in these basal cells was ∆Np63. The decrease observed in the Lonza cells was 
smaller but there was still a decrease. Again, in basal cells, we saw a percentage knockdown efficiency 
between 50-70% for ∆Np63. This was dependent on siRNA concentration when total p63 was knocked 
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down (Figure 21). This again supports that in basal cells the majority of the p63 populous is made up of 
∆Np63.  
When ∆Np63 was examined upon introduction of TAp63 knockdown, it was noted that in HK 
Lonza cells ∆Np63 expression increased. This again supports the idea of each of the isoforms being 
controlled somewhat by each other. When TAp63 isoforms are removed, it appears that ∆Np63 
expression is allowed to increase due to the TAp63 being removed. As previously described, TAp63 is a 
pluristratification marker and blocks differentiation, so when it is removed, ∆Np63 isoforms become more 
prevalent allowing cells to be prepared to differentiate. This pattern was not seen in the HKc17 line. This 
means that too much cannot be derived from what was observed in the HK Lonza, but provides an area 
to investigate further.  
When normal keratinocytes without knockdowns were analyzed through differentiation we 
observed interesting profiles which match the HaCaT data. When we focused on ΔNp63 expression, we 
noted that the fold changes of expression remained constant throughout. This was observed in both the 
HKc13 and 15 cells. Although the fold increases were small compared to the likes of TAp63, the peak 
level of expression was seen around Day 7 of differentiation. The fact that the fold increase was as small 
as it was for ΔNp63, it suggests the level of ΔNp63 remains consistent throughout all stages of 
differentiation. With small changes in expression on Day 0- a pre-differentiation state- suggestions are 
that ΔNp63 has a role to play in basal cells and differentiating cells. This is consistent with suggestions 
made previously that ΔNp63 accounts for the majority of p63 isoforms present in differentiating 
keratinocytes. 
Commonly talked about in the context of keratinocyte differentiation, the role of ∆Np63 isoforms 
appear to be more concerned with maintaining the proliferative potential of cells rather than allowing them 
to proceed towards terminal differentiation. TAp63 may be the agent that prevents the ∆Np63 isoforms 
from maintaining the natural proliferation pattern and interacts with the ∆Np63 isoforms to release cells 
into the differentiation pathway. The processes by which epidermal proliferation are reasonably well 
studied; however, there is still lack of understanding as to how ∆Np63 induces epidermal differentiation. 
A possible role for this regulation is through microRNAs such as miR-944, a ∆Np63 intronic microRNA, 
which are generated from the transcription units of their host so in theory should be expressed at the 
same time. At the basal layer, the proliferative potential of cells is governed by ∆Np63. ERK signaling 
pushes cells towards proliferative capacity; however, when cells migrate into the spinous layer of the 
epidermis the expression of ∆Np63 is reduced. Here the miR-944 acts on cells to induce differentiation. 
It works to reduce ERK signaling and upregulates expression of markers such as p53. By promoting the 
expression of p53, cells are encouraged towards differentiating (Kim et al., 2015).  
ΔNp63 has also been associated with regulating upstream of GATA3, and CHUK. By regulating 
these markers typically associated with terminal differentiation, ΔNp63 is directly involved in this process. 
We see peak expression in differentiating keratinocytes occur around Day7 of differentiation. With a peak 
expression at this time the sequence of events leading to upregulation of transcription factors needed for 
terminal differentiation is started.  
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4.3 ETS-1 
ETS-1 was chosen as a marker to investigate as it has been previously identified as being 
regulated by one of the p63 isoforms in keratinocytes- TAp63. This marker is much like p63 in that it acts 
as a transcription factor, regulating the steps for correct cellular differentiation. ETS-1 has also been 
previously implicated as a transcription factor that regulates CHUK further down the cascade. Through 
microarray analysis, ∆Np63 has been identified as being a regulator of CHUK however it only interacts 
indirectly through GATA-3 regulation (Candi et al., 2006). In comparison, TAp63 regulates ETS-1 in a 
much more direct manner that in turn directly regulates CHUK. In our panel of gene markers, we already 
had structural markers such as FLG and a transcription factor in KLF4, but we wanted two markers that 
not only were regulated by p63 isoforms, but also regulate each other. In ETS-1 and CHUK, we have two 
markers that have been distinctly linked previously.  
During the HaCaT differentiation experiments, ETS-1 expression had a slowly climbing level of 
expression throughout differentiation. This expression peaked at a similar time to TAp63 which falls in 
line with previous studies which suggests that TAp63 directly regulates ETS-1 in keratinocyte 
differentiation (Candi et al., 2007). When the two keratinocyte cell lines (Hkc17 and HK Lonza) were 
exposed to each of the three knockdown assays, they exhibited very similar expression patterns of ETS-
1. Unlike the data obtained for TAp63 and ∆Np63 that varied somewhat between the two cell lines, there 
was a striking similarity when ETS-1 was interrogated. With that being said however, when either cell line 
had TAp63 knocked down, there was an increase, albeit small, in expression of ETS-1. This may be due 
to the assay specificity for TAp63 isoforms not being as desired, which has been previously explored. 
Alternatively, knock down of TAp63 may allow other transcription factors, be it ∆Np63 or others to take 
over the regulation of ETS-1.   
In the literature ETS-1 has been described in the context of expression in keratinocytes 
previously, however there is conflict here also. ETS-1 is an oncogene that is a downstream effector of 
the Ras-MAPK pathway. However, in normal tissues, it has been described as only present in the basal 
layers of the epidermis (Nagarajan et al., 2010). We observed expression in differentiated HaCaT cells 
which is in line with the relationship between ETS-1 and TAp63 described by Candi et al (2007) in terminal 
differentiation but is in contrast to the findings by Nagarajan et al., 2010. Nagarajan et al., 2010 goes on 
to suggest that ectopic expression of ETS-1 in the differentiated layers of the epidermis leads to 
developmental defects and hinders the formation of the barrier. We studied ETS-1 in a 2D culture format 
that would not allow determination of the effect of ETS-1 expression in the differentiated keratinocytes 
and on the barrier function, however we have seen, at least in this cell line, that ETS-1 is present when 
differentiation is in progress. Furthermore, we saw peak expression around Day 11 of differentiation that 
is far from the basal expression described previously.  
Additionally, through the two siRNA-treated cell lines we have reinforced the idea of ETS-1 being 
present in basal cells. Both these lines exhibited similar expression profiles for ETS-1 in each of the 
knockdown conditions. We have demonstrated, at least at the mRNA level, there is expression of ETS-1 
throughout differentiation with data for basal cells (HKc13 and 15) and differentiated cells (HaCaT).  
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4.4 FLG 
During the calcium-induced differentiation of the HaCaT cells, the expression of FLG followed the 
profile as expected. FLG acts as a structural protein that is involved in establishment of the structure of 
the cornified layers and is hence seen in terminally differentiated keratinocytes. The expressed pattern 
we observed matched the expectation that peak expression would be towards terminal differentiation, 
with a slowly increasing level 
throughout. In the HKc13 and HKc15 
cells, we observed similar profiles, 
again with peak expression at the 
later days. FLG has not been 
implicated directly as being regulated 
by either of the p63 isoforms and this 
could be assessed in the future by 
assessing FLG expression when p63 
was knocked down. Once the 
knockdowns are established and fully 
optimized then this can take place.  
As previously mentioned in 
the context of ETS-1 and CHUK, 
GATA 3 is involved with regulating 
FLG in terminal differentiation. This 
transcription factor is expressed in 
epidermal keratinocytes and is 
heavily associated with establishment 
of the epidermal barrier. Additionally, 
in hyperproliferative conditions such as psoriasis, GATA3 expression is decreased in the stratum 
granulosum and stratum spinosum (Zeitvogel et al., 2017). As FLG is directly influenced by GATA3, FLG 
is linked to the network of transcription that regulates CHUK and other markers. This network is controlled 
upstream by the p63 isoforms.  
  4.5 KLF4 
KLF4 gene expression is different, as seen in the HaCaT differentiation. This transcription factor 
has previously been linked to p63 in that there is a level of indirect regulation of KLF4 by p63 (Cordani et 
al., 2010).  This indirect regulation is mediated through p63- regulated expression of ZNF750 which in 
turn allows upregulation of KLF4. Upregulation of KLF4 leads to activation of other terminal differentiation 
genes (Figure 27) (Sen et al., 2012). ZNF750 is crucial for terminal differentiation in keratinocytes as it 
turns on the terminal differentiation sequence, including KLF4.  
Figure 26: Predicted network controlled by p63 isoforms in terminal 
differentiation. CHUK can be regulated indirectly by either p63 
isoform. GATA3 is crucial for allowing the expression of FLG and 
the formation of the epidermal barrier  
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The expression pattern observed in HaCaT cells was similar to what was expected for a 
transcription factor involved in orchestrating terminal differentiation. There is little expression of KLF4 in 
the early stages of differentiation with peak 
expression being around Day 7 with expression 
continuing to be high for a few days before declining 
slowly towards terminal differentiation. This fits with 
the role of KLF4. As a transcription factor, the 
upregulation of KLF4 needs to occur earlier than 
terminal differentiation in order for it carry out its role 
as a transcription factor. KLF4 regulates the 
expression of structural proteins that allow for the 
morphological changes that are identified as 
terminally differentiated keratinocytes. The peak 
expression of KLF4 occurring before peak expression 
of structural proteins make sense given their 
individual roles.  
An interesting area to study in the future 
would be to assess ZNF750 expression and KLF4 
expression when various p63 isoforms are knocked down. In addition, a knockdown of ZNF750 to 
examine the expression of KLF4 without ZNF750 could create significant evidence of this cascade of 
regulation in terminal differentiation.  
KLF4 is highly conserved through evolution, demonstrating its importance as a transcription factor 
associated with development, proliferation and differentiation (Ghaleb & Yang, 2017).  It has come to the 
forefront of research in recent years due to its role in inducing pluripotent stem cells. One of the key 
features of KLF4 is its role in suppressing apoptosis and hence promoting survival. It has been shown to 
suppress the p53- dependent apoptotic pathways. KLF4 is highly expressed in the epidermal layers of 
the skin and mouse models with null KLF4 exhibited a loss of barrier function (Segre et al., 1999). The 
role of KLF4 was identified as its ectopic expression accelerates the barrier formation (Jaubert et al., 
2003).  
The data we obtained supports a correlation between the theory of KLF4 accelerating the 
formation of the external cornified barrier. We saw in HaCaT cells that the expression of KLF4 was highest 
at the later stages of differentiation, but before the peak expression of structural proteins such as FLG. 
This is a correlation between the expression analyses but needs to be investigated further to identify any 
specific causality. This would suggest the structural proteins are the ones being regulated by KLF4 
activity. As a transcription factor, the orchestration of these steps to upregulate structural proteins needs 
to be tightly regulated. A significant upregulation of KLF4 and other transcription factors allows for the 
normal progression and formation of the barrier of the epidermis, allowing for one of the key features of 
the skin.   
4.6 TGM1 
The work carried out on TGM1, this was a continuation on work previous to this study where we 
observed expression of TGM1 in late stages of differentiation (data not shown) in HaCaT cells. To further 
Figure 27: Indirect regulation of KLF4 by p63 
through upregulation of ZNF750. Sen et al., 2012 
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the understanding and assess the viability of HaCaT cells as an expression system for differentiation 
experiments we monitored changes in TGM1 expression in differentiating HKc13 and HKc15 cells. The 
data collected regarding TGM1 expression matched what we saw in HaCaT cells with peak expression 
being towards the later days of differentiation. This also falls in line with TGM1 function as an enzyme 
associated with the formation of the cornified layer in the epidermis. The series of events that creates the 
cornified barrier occurs later in the differentiation process.   
TGM1 was investigated only briefly due to the limited links described between TGM1 and p63 
previously. TGM1 is a hugely important marker for terminal differentiation and is of interest concerning 
downstream regulation from p63. TGM1 is a candidate gene that is associated with disease such as 
congenital ichthyosis and may be implicated in other diseases of the barrier function. With that said, there 
is little evidence in the literature of p63 being involved directly with TGM1 regulation. This would be 
something that would be of interest to investigate further with the implications for disease.  
4.7 Disease 
 Diseases associated with p63 mutation are rare but severe in their phenotype, with a large range 
of developmental defects in epidermal appendages. All forms of ectodermal dysplasia are at a prevalence 
of 1 in 100,000 newborn babies in the USA. These conditions are classically autosomal dominant in 
inheritance meaning only one allele is needed to give a disease genotype. As p63 is so critical for the 
correct formation of the epidermis, and other developmental processes, understanding the exact 
processes that it controls is critical for understanding modes of tackling these diseases. It is complicated 
by the existence of multiple isoforms and the roles they each play in the complex pathways.  
 With work similar to this study, there is data emerging that allows the generation of networks and 
pathways that can be verified in the lab. By creating the networks, we can identify areas that are affected 
by mutated p63 and develop therapeutic approaches to help patients. Additionally, hyperproliferative 
conditions such as psoriasis have been linked to p63 mutation. These conditions are more common than 
the p63-related dysplasia. Restoration of p63 in null animal models has seen a return to wild type so 
using this theory, gene replacement approaches may be an avenue for treatment for these types of 
conditions.   
 Currently there is no available cure for p63-associated disorders. The only available treatments 
are surgery or cosmetic corrections. The rapidly developing field of human disease modelling has allowed 
steps to be made in this area. APR-246/PRIMA-1MET is a small compound that has been discovered in 
the context of cancers, and interacts with the mutant core domain of p53. This compound is in phase I/II 
of clinical trials for treatment of hematological malignancies (Lehmann et al., 2012). Given that p63 is 
from the p53 family, there is significant sequence homology between the two DNA-binding domains 
potentially meaning APR-246 can be used a therapy for p63-related disorders to restore mutant p63 
conformation (Shen et al., 2013).  
 Another strategy, which is being explored, is the use of siRNAs as a therapeutic in treating these 
diseases. Studies focusing on the R304W mutation in EEC rescued defects when a panel of siRNAs 
targeting this mutation were introduced. Furthermore, the siRNA approach also rescued differentiation 
capacity of the cells (Barbaro et al., 2016; Novelli et al., 2016).  
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4.8 Regulation  
 Direct regulation of many genes by p63 is a contributing factor making the picture so complicated 
in respect to unravelling the full networks that it controls. Additionally, the roles of each individual isoform 
and how epidermal formation and barrier function is affected by temporal and spatial expression of p63 
isoforms is of key importance.  
 The control through p63 of many target genes is not the only method of transcriptional control. 
Via higher control, p63 can play a role in epigenetic regulation also. Several studies have demonstrated 
that p63 operates via several independent mechanisms. p63 has been shown to be able to recruit factors 
such as HDAC1/2 to control repression of cell cycle arrest genes. Additionally, many chromatin factors 
are p63 target genes. Recently p63 has been shown to be involved in regulating nuclear envelope 
proteins. In p63 knock out mice, these genes were downregulated suggesting a direct interaction between 
p63 and those genes.  
 New evidence has suggested a role for p63 in regulating enhancers. In cells where p63 is not 
expressed, genomic regions of p63-bound enhancers are inaccessible. The studies also suggest that 
p63 and its related co-regulators have a pioneer effect in epidermal development. The pioneer factors 
are described as the first factors that interact with the chromatin in its compacted state and makes it more 
accessible down the line. This modulation allows for binding of other transcription factors, creating an 
accepting epigenetic environment (Soares & Zhou, 2018). 
 These examples of extra levels of control from p63 further highlight its importance in development 
and disease. The regulation of critical events in a cell’s lifetime result from tightly controlled expression 
of various factors and an unbalance or dysregulation of these events present significant problems. These 
cases also create a curiosity to the scale of regulation that p63 has, further pushing the level of knowledge 
required to understand the full picture.      
 Dysregulation of p63 targets have been studied more in the context of cancers instead of in 
epidermal development. Studies looking at oral development and associated disease and cancers have 
described a dominant negative affect for mutated p63, whereby the mutated form of the protein can 
compromise the functionality of the normal wild type allele. Further studies looking at head and neck 
carcinomas have identified the nature of these dominant negative mutants and how they may disrupt wild 
type p63 activity. There is suggestion in the context of cancers, that mutant p63 isoforms can antagonize 
the regular action of p53, either directly or indirectly. Analysis through Western blots showed that when 
p63 isoforms (ΔNp63) were over expressed in cancer, p53 levels were lacking. Conversely, when p63 
expression was low, p53 was high. In cancer p63 isoforms, particularly ΔNp63 is overexpressed and 
hence the dysregulation of TP63 at the promoter responsible for ΔNp63 isoforms leads to low levels of 
p53. Reduction of p53 activity removes this critical tumor suppressor gene and therefore cancers may 
form (Sniezek et al., 2004). As p53 and p63 have such high sequence, homology it is reasonable to 
expect similar dominant negative effects between isoforms.  
 This is in the context of cancer but demonstrates that changes in the normal expression of p63 
isoforms can lead to catastrophic events in the cell, whether this is through direct dysregulation of target 
genes or via indirect effects.  
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 The TP63 gene is also tightly regulated for proper transcription of the correct isoforms to occur. 
The gene itself is regulated by Notch signaling pathways that are responsible for control of epidermal 
differentiation. Notch signaling has been shown to repress expression of p63 in keratinocytes. This 
pathway is subject to self-feedback loops through ΔNp63 as this isoform can activate Notch associated 
genes. Interferon Regulatory Factor 6 (IRF6), along with p63 mutations, are associated with craniofacial 
malformations such as cleft lip palate. ΔNp63 and IRF6 are closely associated in that IRF6 is activated 
by ΔNp63 and IRF6, surprisingly, causes proteasomal degradation of ΔNp63 (Moretti et al., 2010). Notch 
has also been described as a member of the p63/ IRF6 axis in keratinocytes suggesting a tightly 
organized network to allow for epidermal development. Therefore, if not only p63 is dysregulated but also 
either of the other members in this network are, there could be drastic knock on effects downstream in 
the network, possibly leading to further dysregulation of other genes and potentially disease.  
 Other signaling networks including Hedgehog signaling, Wnt signaling and EGFR pathways have 
all been implicated in being closely involved with regulation of p63 isoforms in the epidermis. This begins 
to show the scale of the network in which p63 is involved; meaning not only is mutation in p63 dangerous 
but mutation and dysregulation of the regulatory members involved with p63 can lead to further issues.  
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5.0 Perspectives 
5.1 Future Work 
 To further this work a number of different angles of investigation can be used. Given more time, 
the first place to start would be to investigate the design of the siRNA assays. These assays appeared 
to show knockdown patterns which were not expected. Repeating these experiments again with the same 
cell lines would allow for a much clearer idea as to if what we were seeing was true. If it is true, then 
potentially redesigning the assays or switching methodological approach completely could be 
considered. As for systems to change to would be shRNA and CRISPR. Both systems create permanent 
knockdowns, which is different to siRNAs that have a transient effect. By switching technique however, 
the specificity problem remains, as currently these systems are not designed with specific p63 isoforms 
in mind. This would need to be explored in more detail before determining the viability of each method. 
 Another way of progressing this work would be to examine the protein expression side of p63 and 
use isoform specific antibodies to look at spatial expression in cell culture and 3D skin models. We have 
acquired specific antibodies for TAp63 and ΔNp63 as well as a pan p63 antibody for this purpose. We 
hope to optimise these antibodies and use them for staining purposes and Western analysis. This 
approach could further be stretched when the knockdown approach was established to include skin 
models that contain certain p63 isoform knockdowns. This would allow assessment of morphological 
features and be used for sectioning and antibody staining in these models. To further the validity of this 
research, the same experiments need to be competed in comparative cell lines from different donors. 
Cell lines, which are matched on age, sex and body area extracted from, should be used to identify if 
these patterns are the same. As information regarding the donors were limited in this case due to the 
nature of the collection, it was difficult to match cells in this way.  
 The method that we want to progress with is to use RNASeq analysis to determine gene 
expression of a whole host of markers from keratinocytes undergoing differentiation. By using a highly 
specific and sensitive technique, it would allow detections of potentially new markers that could be used 
for study in this context whereas qRT-PCR allows for highly specific analysis of known genes. This 
technique provides information on the whole transcriptome in a given cell sample using high throughput 
technologies. Analysis using qRT-PCR would allow for comparison between different cell lines such as 
p63-isoform knockdown lines compared to normal wild type cells. RNASeq is more desirable for this type 
of analysis over the likes of microarrays as it allows for a higher magnitude of data produced (Zhao et al., 
2014).  
 Using the mRNA level as a method of study has merit in that it allows gene expression to be 
studied and this can provide information into the changes that occur during differentiation. However, this 
analysis needs to be reinforced by protein analysis, as protein expression can provide a bigger insight 
into the changes. Protein expression can have a higher impact on differentiation and cellular phenotype 
so must be considered before conclusions are made. Coupled together, both gene expression and 
protein expression provide more of a perspective into the networks involved. 
 As the network of transcriptional control in keratinocyte differentiation is complex, it would be 
beneficial to identify and investigate other markers involved in this process. By identifying multiple 
members of these cascades, the whole picture of the regulatory network can begin to be hypothesised. 
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This will have impact on disease applications as different markers can be investigated as candidate genes 
for various developmental and epidermal conditions. By examining the normal processes, comparison to 
patient skin can be used to identify genes involved. This will have impact not only when looking at p63-
related diseases such as AEC and EEC, but also hyperproliferative conditions such as psoriasis and 
even eczema.  
 In the literature, there is still conflict into the specific roles of p63 isoforms with debate over not 
only specific roles but also the temporal expression of the isoforms. It is widely accepted that ΔNp63 is 
the most prominent isoform in differentiating keratinocytes and has roles in maintaining the basal layer 
whilst also allowing for proliferative potential in the keratinocytes. Recently with more developed 
technologies, there has been progress in identifying specific roles for the p63 isoforms. The generation 
of the ΔNp63 knockout mouse has shed light into the importance of these isoforms for development. Null 
mice show poorly developed epithelia, including the epidermis. This demonstrates that this particular 
isoform is responsible for epithelia development and maintenance of epithelial stem cells (Romano et al., 
2012). As for TAp63-null animals, the phenotypes included premature ageing, alteration to glucose and 
lipid metabolism and eventually premature death (Su et al., 2012; Su et al., 2009).   
 Generation of these models shows progress in the area, allowing for more specific 
experimentation regarding individual isoforms. These models will be crucial for progressing the 
understanding of the interplay between p63 isoforms and other genes in a live model. Obviously, there 
are limitations of mice models such as the ethical issues surrounding animal models. Furthermore, the 
skin of the mouse differs from human skin due to higher numbers of follicles in mouse. This may affect 
any staining experiments. This leads to generation of knock out cell lines that can be used on large scale 
without the issues of ethical confrontation or other issues arising from mouse models. These cell model-
based approaches are beneficial as cell lines can be generated with isoform knockdowns that can be 
stored and reproduced on a commercial scale, allowing for a larger amount of research into roles of p63.  
 Production of these lines would vastly improve the speed at which gene expression studies 
related to p63 isoforms could be produced. This could have benefits in the pharmaceutical or gene 
therapy markets as currently patients with p63-related conditions have limited treatments. In mouse 
models, reintroduction of p63 in null subjects showed a level of restoration of the wild-type phenotype 
that could be an avenue for investigation through gene therapy applications.  
5.2 Conclusion 
 As a preliminary study into the role of p63 isoforms in keratinocyte differentiation, we have 
managed to identify the normal expression patterns of both ∆Np63 and TAp63 expression in 
differentiating keratinocytes. Alongside the p63 isoforms, we have also assessed expression of other 
differentiation markers including FLG, ETS-1 and KLF4. We have identified that during normal 
differentiation, the expression of the isoforms appears to have mirrored profiles with ∆Np63 expression 
peaking early and decreasing towards terminal differentiation with TAp63 expression climbing at this 
time. Peak TAp63 expression was observed around Day11 of differentiation suggesting a role for these 
isoforms in regulating the final steps. There has been recent work that has highlighted this expression of 
TAp63 isoforms and speculation into their roles are at an early stage. By removing TAp63 expression 
through transient knockdowns in basal cells, we have demonstrated a system that can effectively reduce 
TAp63 expression; however, we have experienced some cross reactivity with the ∆Np63 isoforms. By 
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furthering the system through optimization and developing the methods, we hope to knock down TAp63 
isoforms solely and investigate the effects that has on terminal differentiation. With so much data present 
on ∆Np63 isoforms in this context, there is a need for a shift in focus to TAp63 isoforms in order to 
understand fully its role here.  
 Despite the difficulties found in this study there are exciting possibilities that have emerged for 
further work. Through the literature, we can gather more information for target genes to assess alongside 
p63 to elucidate the networks in which p63 isoforms are involved. Along with the siRNA knockdown, 
verification through alternative methods can provide evidence for the regulatory role of each of the 
isoforms. The aims of this study were to develop siRNA knockout systems that are isoform specific and 
allow for study of individual isoforms in differentiating keratinocytes. The use of siRNAs has some 
downfalls in that they are transient and have limited lifespans but this technology is the most feasible at 
this current time. There need to be reconsiderations in our case for the specific sequences and regions 
used, but this technology allows for the study of knockdown keratinocytes.  
There is a need for the technology to develop in order to create isoform-specific systems that 
reduces the cross-reactivity and non-specific binding of primers currently. This lack of specific 
technologies mean alternative measures need to be taken, as with this study. Inconsistencies in the 
findings of literature could be caused by the lack of very specific systems.  
 The area of p63 in the context of keratinocyte differentiation is an exciting one as with the 
discovery of the individual isoforms creates a huge amount that is needed to be understood not only to 
map the relevant networks but also to help combat rare epidermal disease.  
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7.3 Research proposal 
Research proposal: The Importance of Transcription Factor p63 in 
Epidermal Development and Disease- focus on TAp63 Isoforms.  
Background: The epidermis is the outermost layer of the skin- the largest organ in the human 
body. The epidermis provides protection for the internal environment of the body. The epidermis 
is divided into layers which play key roles in maintaining a barrier to pathogens, whilst also 
regulating the movement of desired molecules into the body; and unwanted out of the body 
(Zhao et al., 2015).  
Keratinocytes are the most abundant cells in the epidermis. These cells produce proteins called 
keratins which play crucial roles in the maintenance of this layer. Regulating the transcription of 
the genes for these keratins are a group of transcription factors. One of the key transcription 
factors found in keratinocytes is p63, a protein encoded by the TP63 gene. This protein is from 
the p53 family and is known to regulate thousands of genes, many of which are key to epidermal 
development and differentiation of keratinocytes. As a result, when mutation in this gene occurs 
it leads to developmental conditions which can have aggressive phenotypes.  
The TP63 gene contains two distinct promoters which gives rise to two forms of the p63 protein- 
the TAp63 forms and the ΔNp63 forms of which the ΔNp63 form lacks a transactivation domain 
at the 5’ end. Within these two groups, alternative splicing of the TP63 gene gives rise to a total 
of 6 common isoforms (TAp63 α, β and γ/ ΔNp63 α β and γ) (Candi, Rufini, et al., 2006). Of 
these isoforms lots of work has been done previously to uncover the function of the ΔNp63 forms 
as these are most abundant during the differentiation pathways within keratinocytes. In addition, 
relative expression of ΔNp63 forms is higher than that of TAp63. Despite this, recent work has 
suggested that TAp63 may actually be over-expressed in the later days of differentiation, during 
the formation of the cornified layer (Koh et al., 2015).  
Very little research has distinctly focused on the TAp63 isoforms and their transcriptional target. 
Despite this, recent work has suggested that TAp63 may actually be over expressed in the later 
days of differentiation, during the formation of the cornified layer. This means there is gap in the 
knowledge about this group which may have crucial roles in orchestrating the final steps during 
keratinocyte differentiation. Moreover, there is still conflict within the community as to whether 
TAp63 forms and ΔNp63 work cooperatively or in an antagonistic fashion during the 
differentiation pathway.  
Given the limited knowledge on this group of isoforms, it is possible that they may have 
implications in disease associated with the skin cornification process or terminal differentiation. 
Loss of function, or limited function of these transcription factors may cause the cascade of 
events which lead to terminal differentiation not occurring or being less efficient.  
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In recent literature, some transcriptional targets for the TAp63 group of isoforms have begun to 
be uncovered through a variety of techniques such as microarrays and over expression of the 
isoforms in vitro (Koh et al., 2015; Truong et al., 2006). Despite this, many targets are still not 
known. These identified targets can be used as markers for assessment of the knockdown of 
TAp63. If when TAp63 is knocked down the marker is not expressed, or is expressed less, then 
TAp63 may be the transcriptional controller associated with that marker.  
Aims: This project aims to continue work that has been started by the group into the key roles 
of the transcription factor p63 and most notably the function and transcriptional targets of the 
TAp63 group of isoforms. This work will look into the temporal expression patterns of the p63 
isoforms during the process of keratinocyte differentiation whilst comparing to morphological 
changes which occur during this process. In addition, histological staining of differentiation 
markers will allow spatial expression to be analysed. This work will include work with primary 
keratinocytes obtained from patient samples, whilst also using control lines such as immortalised 
HaCaT cells as comparison.  
Furthermore, this work will look to determine the transcriptional targets of the TAp63 group of 
isoforms that are crucial during keratinocyte differentiation. This work may be achieved via use 
of siRNA to knockdown the TAp63 gene. Alongside monitoring the effects on potential TAp63 
targets during knockdown, this can be compared to the morphology of the cells to assess if the 
cornified layer actually forms when TAp63 is knocked down.  
Methodology: Initial work with this project will involve a cell culture-based approach to culture 
the cell lines. The cell lines to be used will include immortalised keratinocytes (HaCaT) and 
primary keratinocytes from patient samples. The cells are to be maintained in a basal phenotype 
and then encouraged to begin the process of differentiation by addition of calcium to the media. 
Cells will be harvested on pre-defined time points to allow RNA to be extracted. Photographs 
will be taken to assess morphological changes. This RNA will be reverse transcribed into cDNA 
which will then be analysed via qRT-PCR using TaqMan assays to determine relative 
expression.  
Beyond this, depending on results obtained, knockdown of the TAp63 gene via siRNA will be 
carried out. Markers which are transcriptional targets for the TAp63 isoforms will be used to 
assess the effect of this knockdown during the process of differentiation.  
Also, histological work on embedded or frozen sections will be carried out to allow the marrying 
of spatial expression to temporal expression to provide a clear overview of the expression and 
hence the role of the TAp63 isoforms.  
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7.4 COSHH  
7.4.1 Cell counting using a haemocytometer  
Assessment Carried 
Out by:   REF.NO, 
  
Purpose of 
Assessment Teaching 
  
Projects 
x 
Research 
Activity 
  
Technical Prep 
  
  
Module Name (where 
applicable) Research Project SHB4001 Module No. 
  
  
Supervisor Name 
(where applicable) Dr Hans Hennies Extension No. 
  
  
Activity Assessed: Counting cells      
Those at risk from this 
activity: Academic Staff 
  
Technicians 
  
Researchers 
  
Students 
x 
Visitors 
  
               
Substance, mixture, organism 
etc 
Signal 
Word Hazard Code and Phrases Route of Entry Risk 1 
Nitrotetrazolium Blue chloride Warning 
H302: Harmful if swallowed Ingestion 
  H371: May cause damage to organs Inhalation 
    
Factors affecting risk e.g state, 
quantity, handling etc Precautionary Phrases Controls Risk 2 
Acute Toxicity, Oral (Category 4), 
H302, Specific target organ 
toxicity- single exposure 
P260: Do not breathe dust/fume/gas/mist/vapours/spray Surveillance 
  P308: IF exposed or concerned:   
P311: Call a POISON CENTER or doctor/physician   
 
7.4.2 General cell culture 
Assessment Carried Out 
by:   REF.NO, 
  
Purpose of Assessment 
Teachin
g 
  
Project
s 
x 
Research Activity 
  
Technical 
Prep 
  
  
Module Name (where 
applicable) Research Project SHB4001 Module No. 
  
  
Supervisor Name (where 
applicable) Dr Hans Hennies Extension No. 
  
  
Activity Assessed: Cell Culture with HaCaT/ keratinocyte cell line      
Those at risk from this 
activity: Academic Staff 
  
Technicians 
  
Researchers 
  
Stu
den
ts 
x 
Vi
si
to
rs 
  
               
Substance, mixture, organism etc 
Signal 
Word Hazard Code and Phrases 
Route of 
Entry Risk 1 
DMEM Media (no Gln, no Ca2+) Warning 
H303: May be harmful if swallowed Ingestion 
Low H313: May be harmful in contact with skin Skin Contact 
H333: May be harmful if inhaled Inhalation 
Factors affecting risk e.g state, 
quantity, handling etc Precautionary Phrases Controls 
Risk 
2 
PAGE 82 
 
 
  
P302+352: IF ON SKIN: Wash with soap and water 
Lab Coat, 
Spectacles and 
Gloves 
Low 
P305+351+338: IF IN EYES: Rinse cautiously with water for several 
minutes. Remove contact lenses if present and easy to do – continue 
rinsing 
Spectacles 
P304+341: IF INHALED: If breathing is difficult, remove victim to 
fresh air and keep at rest in a position comfortable for breathing 
  
               
Substance, mixture, organism etc 
Signal 
Word Hazard Code and Phrases 
Route of 
Entry 
Risk 
1 
Foetal Bovine Serum Warning 
H303: May be harmful if swallowed Ingestion 
Low H333: May be harmful if inhaled Inhalation 
H313: May be harmful in contact with skin Skin Contact 
Factors affecting risk e.g state, 
quantity, handling etc Precautionary Phrases Controls 
Risk 
2 
The product does not contain any 
substances at their given 
concentrations are harmful to health 
P302+352: IF ON SKIN: Wash with soap and water 
Lab Coat, 
Spectacles and 
Gloves 
  
P304+341: IF INHALED: If breathing is difficult, remove victim to 
fresh air and keep at rest in a position comfortable for breathing 
  
P305+351+338: IF IN EYES: Rinse cautiously with water for several 
minutes. Remove contact lenses if present and easy to do – continue 
rinsing 
Spectacles 
               
Substance, mixture, organism etc 
Signal 
Word Hazard Code and Phrases 
Route of 
Entry 
Risk 
1 
Chelex 100 sodium form Warning 
H303: May be harmful if swallowed Ingestion 
Low H313: May be harmful in contact with skin Skin Contact 
H333: May be harmful if inhaled Inhalation 
Factors affecting risk e.g state, 
quantity, handling etc Precautionary Phrases Controls 
Risk 
2 
Not a hazardous substance or mixture 
according to regulation (EC) No. 
1272/2008. Not classified as dangerous 
according to directive 67/548/EEC. 
P302+352: IF ON SKIN: Wash with soap and water 
Lab Coat, 
Spectacles and 
Gloves 
  
P304+341: IF INHALED: If breathing is difficult, remove victim to 
fresh air and keep at rest in a position comfortable for breathing 
Monitoring 
P305+351+338: IF IN EYES: Rinse cautiously with water for several 
minutes. Remove contact lenses if present and easy to do – continue 
rinsing 
Lab Coat and 
Spectacles 
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7.5 Cell Culture Volumes- University of Huddersfield Dermatogenetics  
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7.6 RNA Extraction Protocol- Applied Biosystems  
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7.7 cDNA Synthesis Protocol: Applied Biosystems 
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7.8 qRT-PCR Protocol: Modified from ThermoFisher Scientific 
qRT-PCR was carried out for analysing different primers and housekeeping genes on keratinocyte 
samples. A reaction mix for the Master Mix plus the assay primer and probe mix was prepared. 
Furthermore, a sample mix for each cDNA was prepared as well.  
Table 5. Quantities of Master Mix, primer, cDNA and distilled water for every plate.  
Reaction Component 1x reaction  25x reaction (for 24 wells 
on one plate) 
Reaction 
Mix 
Master Mix  5 µL 125 µL 
Assay primer and probe mix 0.5 µL 12.5 µL 
Sample Mix 
cDNA diluted  1 µL 10 µL 
Distilled water  3.5 µL 35 µL 
  
A fresh PCR fast plate was put on ice and 5.5 µL of the reaction mix were pipetted into the correct well 
until the plate was full. When it was ready 4.5 µL of sample mix were added to each row. Then the plate 
was covered with an adhesive film and centrifuged. The plate was put into the StepOnePlusTM Real-Time 
PCR System and the template was adjusted to the correct samples to be run and to analyse the results.  
 
Figure 7. Drawing of the plate with the samples and primers. 
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7.9 siRNA Transfection Protocol: ThermoFisher Scientific 
Protocol - Stealth RNAi or siRNA Transfection 
Use this brief procedure to transfect Stealth RNAi or siRNA into mammalian cells in a 24-well format. All 
amounts and volumes are given on a per well basis. Use this procedure as a starting point; optimize transfections 
as described in Optimizing Stealth RNAi or siRNA Transfection, especially if you are transfecting a 
mammalian cell line for the first time. 
1. One day before transfection, plate cells in 500 µl of growth medium without antibiotics such that they will 
be 30-50% confluent at the time of transfection. Note: Transfecting cells at a lower density allows a longer 
interval between transfection and assay time, and minimizes the loss of cell viability due to cell 
overgrowth. 
2. For each transfection sample, prepare oligomer-Lipofectamine 2000 complexes as follows: 
o A. Dilute 20 pmol Stealth RNAi or siRNA oligomer in 50 µl Gibco™ Opti-MEM™ I Reduced Serum 
Medium without serum (resulting concentration of RNA in Opti-MEM is 400 nM). Mix gently 
o B. Mix Lipofectamine 2000 gently before use, then dilute 1 µl in 50 µl OptiMEM I Reduced Serum 
Medium. Mix gently and incubate for 5 minutes at room temperature. Note: Proceed to the next step 
within 25 minutes. 
o C. After the 5-minute incubation, combine the diluted oligomer with the diluted Lipofectamine 2000. Mix 
gently and incubate for 20 minutes at room temperature (solution may appear cloudy). 
       
3. Add the oligomer-Lipofectamine 2000 complexes to each well containing cells and medium. Mix gently by 
rocking the plate back and forth. 
Incubate the cells at 37°C in a CO2 incubator for 24-96 hours until you are ready to assay for gene knockdown. 
Medium may be changed after 4-6 hours. 
Optimizing Stealth RNAi or siRNA Transfection 
To obtain the highest transfection efficiency and low non-specific effects, optimize transfection conditions by 
varying RNA and Lipofectamine 2000 concentrations. Test 10-10pmol/μl RNA and 0.5-1.5 µl Lipofectamine 2000 
for 24-well format. Depending on the nature of the target gene, transfecting cells at higher densities may also be 
considered when optimizing conditions. 
Scaling Up or Down Transfections 
To transfect cells in different tissue culture formats, vary the amounts of Lipofectamine 2000, nucleic acid, cells, 
and medium used in proportion to the relative surface area, as shown in the table. With automated, high-
throughput systems, a complexing volume of 50 µl is recommended for transfections in 96-well plates. 
Note: You may perform rapid 96-well plate transfections by plating cells directly into the transfection mix. Prepare 
complexes in the plate and directly add cells at twice the cell density as in the basic protocol in a 100 µl volume. 
Cells will adhere as usual in the presence of complexes. 
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Culture 
vessel 
Surf. 
area 
per 
well1 
Shared reagents DNA transfection RNAi transfection 
 
Vol. of 
plating 
medium 
Vol. of 
dilution 
medium2 
DNA Lipofectamine 
2000 
RNA Lipofectamine 
2000 
96-well 0.3 
cm 2 
100 µL 2 x 25 µL 0.2 
µg 
      0.5 µL  5 pmol     0.25 µL 
24-well 2 
cm 2 
500 µL 2 x 50 µL 0.8 
µg 
      2.0 µL  20 pmol       1.0 µL 
12-well 4 
cm 2 
1 mL 2 x 100 µL 1.6 
µg 
      4.0 µL  40 pmol       2.0 µl 
6-well 10 
cm 2 
2 mL 2 x 250 µL 4.0 
µg 
      10 µL 20pmol/μl         5 µL 
60-mm 20 
cm 2 
5 mL 2 x 0.5 mL 8.0 
µg 
      20 µl 200 pmol       10 µL 
10-cm 60 
cm 2 
15 mL 2 x 1.5 mL 24 µg       60 µL 600 pmol       30 µL 
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7.10 Abstract for previously published work 
The role of p63 isoforms in the epidermal development as replicated in cellular models for normal human 
skin and genetic skin diseases 
Inmaculada Barragán Vázquez1,2, Dulce Lima Cunha1,3,4, Sean Hockney1, Kar Yeun Tang1, Sari 
Thomforde Kitson1, Katja Martina Eckl5, Hans Christian Hennies1,3,4,6 
1 Dermatogenetics, Dept. of Biological Sciences, University of Huddersfield, UK 
2 Faculty of Chemical Sciences, Universidad Complutense de Madrid, Spain 
3 Genetics and Genomics, Medical University of Innsbruck, Austria 
4 Cologne Center for Genomics, University of Cologne, Germany 
5 Dept. of Biology, Edge Hill University, Ormskirk, UK 
6 CECAD, University of Cologne, Cologne, Germany 
Transcription factor p63 is a key regulator of epidermal development. TP63 codes for two major isoforms, 
TAp63 and ΔNp63. Mutations in TP63 are associated with severe diseases such as 
ectrodactyly/ectodermal dysplasia and cleft lip/palate (EEC) and ankyloblepharon/ectodermal defects 
and cleft lip/palate (AEC) syndromes. These diseases and knockout and transgenic mice pointed to a 
major role of p63 in ectodermal development. Details about the importance of the isoforms are not clear 
so far; TAp63 is present early in ectodermal development, ΔNp63 is involved in epidermal maturation. In 
order to study the importance of p63 for epidermal differentiation, we have analysed the expression of 
TP63 and its major isoforms in keratinocytes in vitro. Quantitative real time PCR revealed a minor 
increase early in Ca2+ induced differentiation of primary human normal epidermal keratinocytes and a 
decrease during terminal differentiation. Isoform-specific analysis showed that ΔNp63, the predominant 
isoform in epidermis, was present during differentiation with decreasing levels. TAp63, in contrast, 
showed an increase late in differentiation after 10d in culture. These results are in accordance with an 
association of ΔNp63 with basal epidermal keratins 5 and 14 and a declining expression in suprabasal 
epidermal layers as shown previously by immunohistochemistry. KLF, a transcription factor gene 
important for gene expression in terminally differentiating keratinocytes, showed an increase in parallel 
with the increase of differentiation markers such as transglutaminase 1 and filaggrin, which is in line with 
the supposed induction of KLF by p63. Keratinocytes of patients with autosomal recessive congenital 
ichthyosis (ARCI), a disorder of epidermal keratinisation, showed a similar pattern for the expression of 
TP63, indicating that the disturbed keratinisation seen in ARCI is restricted to proteins of terminally 
differentiating keratinocytes but does not influence their transcription factors. Our findings underpin the 
importance of switching p63 isoforms during epidermal development and confirm an additional role for 
TAp63 in terminal differentiation. Moreover, these results corroborate the importance of cellular models 
based on primary keratinocytes for the study of epidermal keratinisation. Studies with 3D human skin 
models will give further insight into the regulation of gene expression profiles during epidermal 
differentiation. 
